ESPE Abstracts

Contents

• Plenary Lectures
• • Impact of GH treatment on DNA damage
  • • Impact of GH on DNA Damage

      hrp0098pl1
  • Addressing Inequalities in Child Health. Lessons from the UK policy experiments in poverty and adversity
  • • Abstract unavailable

      hrp0098pl2
  • Precision medicine in monogenic obesity
  • • Abstract unavailable

      hrp0098pl3
  • The importance of chronobiology for medicine – when time matters
  • • Abstract unavailable

      hrp0098pl4
  • MKRN3 and the initiation of puberty
  • • MKRN3 and the initiation of puberty

      hrp0098pl5
  • Pancreatic and islet plasticity in early life: implications for diabetes risk
  • • Abstract unavailable

      hrp0098pl6
  • Fat & Bone; where are we now?
  • • Bone and Fat: Where are We Now?

      hrp0098pl7
  • Genomics in Rare Diseases
  • • Abstract unavailable

      hrp0098pl8
• Symposia
• • Disorders of Sex Development: Novel advances in management
  • • Abstract unavailable

      hrp0098s1.1
    • Novel mechanisms leading to DSD (genomic, digenic/oligogenic and non-coding variation)

      hrp0098s1.2
    • Hypospadias- surgery and beyond

      hrp0098s1.3
  • Bone and Mineral Disorders: Recent Developments
  • • Phosphate sensing in normal physiology and disease

      hrp0098s2.1
    • Abstract unavailable

      hrp0098s2.2
    • PTH Resistance Syndromes

      hrp0098s2.3
  • Novel Advances in the Treatment of Hypothalamic disease
  • • Abstract unavailable

      hrp0098s3.1
    • Use of MC4R agonist in hypothalamic obesity

      hrp0098s3.2
    • Abstract unavailable

      hrp0098s3.3
  • New Adjuvant Therapy in Pediatric Diabetes (Joint ISPAD‐ESPE Symposium)
  • • Use of Verapamil in newly diagnosed T1D

      hrp0098s4.1
    • Abstract unavailable

      hrp0098s4.2
    • Statins and cardiovascular risk in type 1 diabetes

      hrp0098s4.3
  • Adrenal Disorders
  • • Innovations in pharmacotherapy for congenital adrenal hyperplasia

      hrp0098s5.1
    • Translational Clinical Applications of Complex Steroidobolome Data

      hrp0098s5.2
    • Lessons from CAH service evaluation and real-world data

      hrp0098s5.3
  • Novel Insights into Pituitary Disorders
  • • Abstract unavailable

      hrp0098s6.1
    • Early postnatal pituitary stem cells mostly generate gonadotrophs

      hrp0098s6.2
    • Management of idiopathic pituitary stalk thickening

      hrp0098s6.3
  • Future hope for skeletal disorders
  • • Stem cells in skeletal development and growth

      hrp0098s7.1
    • Abstract unavailable

      hrp0098s7.2
    • Consensus statement on management of achondroplasia

      hrp0098s7.3
  • Improving treatment strategies in Obesity
  • • Pharmacotherapy of Obesity

      hrp0098s8.1
    • The Impact of Adolescent Overweight and Obesity on Adult Morbidity and Mortality

      hrp0098s8.2
    • Bariatric Surgery: Impact Beyond Weight Loss

      hrp0098s8.3
  • Novel advances in paediatric thyroid disease
  • • Genetics of congenital hypothyroidism: Modern concepts

      hrp0098s9.1
    • Pediatric thyroid cancer guidelines: challenges in stratifying care based on limited data

      hrp0098s9.2
    • Abstract unavailable

      hrp0098s9.3
  • Challenges in the management of Prader Willi Syndrome
  • • Abstract unavailable

      hrp0098s10.1
    • Abstract unavailable

      hrp0098s10.2
    • Growth hormone treatment in adults with PWS

      hrp0098s10.3
  • Microbiota in type 1 diabetes
  • • Gut dysbiosis in type 1 diabetes

      hrp0098s11.1
    • Abstract unavailable

      hrp0098s11.2
    • Abstract unavailable

      hrp0098s11.3
  • The impact of gonadotrophin dysregulation on neurocognition
  • • The Role of MiniPuberty in Non-Reproductive Outcomes

      hrp0098s12.1
    • Neurodevelopmental syndromes associated with central precocious puberty

      hrp0098s12.2
    • Studying the genetic interplay between GnRH deficiency and associated neurocognitive disorders by combining in silico, in vitro and in vivo tools

      hrp0098s12.3
• Meet the Expert
• • Genetic Testing in Hypogonadism
  • • Abstract unavailable

      hrp0098mte1
  • Management of Lipodystrophy
  • • Abstract unavailable

      hrp0098mte2
  • Pharmacological treatment options for adolescents with Obesity
  • • Abstract unavailable

      hrp0098mte3
  • Closed loop in the very young child with Type 1 Diabetes
  • • Abstract unavailable

      hrp0098mte4
  • Managing difficult menstrual periods
  • • Abstract unavailable

      hrp0098mte5
  • Management of sodium and water regulation disorders
  • • Abstract unavailable

      hrp0098mte6
  • Diagnosis and Management of PCOS
  • • Abstract unavailable

      hrp0098mte7
  • The Diagnosis & Management of Rickets in the 21st Century
  • • Abstract unavailable

      hrp0098mte8
• How Do I…
• • How Do I… Session 1
  • • Abstract unavailable

      hrp0098hdi1.1
    • Abstract unavailable

      hrp0098hdi1.2
    • How do I... Manage the infant with hypoglycaemia

      hrp0098hdi1.3
  • How Do I… Session 2
  • • Abstract unavailable

      hrp0098hdi2.1
    • Abstract unavailable

      hrp0098hdi2.2
    • Abstract unavailable

      hrp0098hdi2.3
• Controversies
• • Should we restrict height in tall stature?
  • • Controversy: Should we restrict height in tall stature?

      hrp0098con1
• Novel Advances
• • Novel Advances Session
  • • Abstract unavailable

      hrp0098na1
• Young Investigators
• • Section
  • • Abstract unavailable

      hrp0098yi1.1
    • Abstract unavailable

      hrp0098yi1.2
    • Abstract unavailable

      hrp0098yi1.3
• Working Group Symposia
• • ESPE Working Group on Obesity
  • • Abstract unavailable

      hrp0098wg1.1
    • Abstract unavailable

      hrp0098wg1.2
    • Abstract unavailable

      hrp0098wg1.3
    • Abstract unavailable

      hrp0098wg1.4
  • ESPE Working Group on Gender Incongruence
  • • Immunological effects of gender-affirming hormone treatment

      hrp0098wg2.1
    • Abstract unavailable

      hrp0098wg2.2
    • Abstract unavailable

      hrp0098wg2.3
  • ESPE Working Group on Paediatric and Adolescent Gynaecology
  • • Abstract unavailable

      hrp0098wg3.1
    • Abstract unavailable

      hrp0098wg3.2
    • Fertility preservation in girls

      hrp0098wg3.3
  • ESPE Working Group on Turner Syndrome
  • • Abstract unavailable

      hrp0098wg4.1
    • Beyond growth and puberty – monitoring co-morbidities in Turner syndrome

      hrp0098wg4.2
    • Turner syndrome and care during adulthood

      hrp0098wg4.3
    • Abstract unavailable

      hrp0098wg4.4
    • Abstract unavailable

      hrp0098wg4.5
  • ESPE Working Group on Bone and Growth Plate
  • • Abstract unavailable

      hrp0098wg5.1
    • Abstract unavailable

      hrp0098wg5.2
    • Abstract unavailable

      hrp0098wg5.3
  • ESPE Working Group on Gender Dysphoria (GD) Symposium
  • • Abstract unavailable

      hrp0098wg6.1
    • Abstract unavailable

      hrp0098wg6.2
    • Abstract unavailable

      hrp0098wg6.3
  • ESPE Working Group for Paediatric Endocrine Nurses
  • • Abstract unavailable

      hrp0098wg7.1
    • Abstract unavailable

      hrp0098wg7.2
    • Abstract unavailable

      hrp0098wg7.3
  • ESPE Working Group on Disorders/Differences of Sex Development
  • • Abstract unavailable

      hrp0098wg8.1
    • Abstract unavailable

      hrp0098wg8.2
• Endo‐ERN Symposium
• • Section
  • • Abstract unavailable

      hrp0098ee1.1
    • Abstract unavailable

      hrp0098ee1.2
    • Genetic testing in rare forms of primary adrenal insufficiency

      hrp0098ee1.3
    • The patient perspective on new treatment options (example hypogonadotropic hypogonadism)

      hrp0098ee1.4
• ESPE‐ESE Joint Symposium
• • Section
  • • Abstract unavailable

      hrp0098es1.1
    • Prenatal Exposure to Over-the-Counter Antifungal Drugs Affects Fetal Steroidogenesis and is Associated with Persistent Effects in Children

      hrp0098es1.2
    • Abstract unavailable

      hrp0098es1.3
• ESPE Yearbook Sessions
• • Year of Paediatric Endocrinology 1
  • • Abstract unavailable

      hrp0098yb1.1
    • Abstract unavailable

      hrp0098yb1.2
    • Abstract unavailable

      hrp0098yb1.3
    • Abstract unavailable

      hrp0098yb1.4
    • Abstract unavailable

      hrp0098yb1.5
  • Year of Paediatric Endocrinology 2
  • • Abstract unavailable

      hrp0098yb2.1
    • Abstract unavailable

      hrp0098yb2.2
    • Abstract unavailable

      hrp0098yb2.3
    • Abstract unavailable

      hrp0098yb2.4
    • Abstract unavailable

      hrp0098yb2.5
  • Year of Paediatric Endocrinology 3
  • • Abstract unavailable

      hrp0098yb3.1
    • Abstract unavailable

      hrp0098yb3.2
    • Abstract unavailable

      hrp0098yb3.3
    • Abstract unavailable

      hrp0098yb3.4
    • Abstract unavailable

      hrp0098yb3.5
• Henning Andersen Award Winners
• • Biallelic missense FDX1 mutation causes congenital adrenal hyperplasia with 11β‐hydroxylase deficiency and vitamin D‐resistant bone rickets
  • • Biallelic missense FDX1 mutation causes congenital adrenal hyperplasia with 11β-hydroxylase deficiency and vitamin D-resistant bone rickets

      hrp0098ha1
  • A novel human disorder: QSOX2 deficiency‐induced growth restriction, gastrointestinal dysmotility and immune dysfunction highlights a new mechanism of disease.
  • • A novel human disorder: QSOX2 deficiency-induced growth restriction, gastrointestinal dysmotility and immune dysfunction highlights a new mechanism of disease

      hrp0098ha2
• Free Communications
• • Diabetes and Insulin
  • • Does Type 1 Diabetes Effect Left Ventricular Function in Children? Evaluation with Treadmill Exercise Stress Echocardiography

      hrp0098fc1.1
    • Effect of hydroxychloroquine therapy in newly diagnosed type 1 diabetes: a randomised, double-blind, placebo-control pilot trial

      hrp0098fc1.2
    • A Non-Invasive Diagnostic Tool for Early Detection of Microvascular Alterations in Children with Type 1 Diabetes Mellitus: Nail-Fold Capillaroscopy

      hrp0098fc1.3
    • A personalized approach to classify the degree of liver insulin resistance in children with obesity

      hrp0098fc1.4
    • The Side-Effects of Lanreotide in Children with Congenital Hyperinsulinism (CHI): A Decade-long Exploration

      hrp0098fc1.5
    • Comprehensive rescreening of the known congenital hyperinsulinism genes provides a new genetic diagnosis for 18% of the Finnish cohort

      hrp0098fc1.6
  • Bone, Growth Plate and Mineral Metabolism
  • • A highly selective FGFR3 inhibitor alleviates achondroplasia symptoms and restores chondrocyte growth in mice model

      hrp0098fc2.1
    • Therapeutic Effects of Human Bone Marrow Mesenchymal Stem Cells Derived Exosomes on Glucocorticoid-Induced Osteoporosis: In Vitro Model

      hrp0098fc2.2
    • Molecular mechanism of FBN1 variants result to acromicric dysplasia by mechano-transduction

      hrp0098fc2.3
    • Analysis of baseline data from the SUNFLOWER longitudinal, observational cohort study of patients with XLH: relationship between various complications and QOL

      hrp0098fc2.4
    • Bone health in adolescents with cow’s milk allergy during infancy

      hrp0098fc2.5
    • Expansion of the CrescNet Registry Achondroplasia Module: Real-World Demographic Data and Outcomes After up to 2 Years of Vosoritide Treatment

      hrp0098fc2.6
  • Pituitary, Neuroendocrinology and Puberty 1
  • • The Effects of Blue Light Exposure on the Epiphyseal Plate and IGF1 - IGFBP3 Expression in Rats

      hrp0098fc3.1
    • Disruption of the Wnt-antagonist APC in the pituitary stem cells is a driver of adamantinomatous craniopharyngioma

      hrp0098fc3.2
    • Analysis of clinical factors affecting retinal ganglion cell complex thickness reduction in patients with childhood onset craniopharyngioma

      hrp0098fc3.3
    • The spectrum of Endocrinopathies in Children with Ectopic Posterior Pituitary (EPP) correlates with the severity of associated hypothalamo-pituitary abnormalities on imaging: a decade long experience from two tertiary centers

      hrp0098fc3.4
    • Screening for First Morning Voided (FMV) Urinary Gonadotropin (Gn) in Children with Normal and Precocious Puberty (PP): A Prospective, Multi-Center, Large-Sample based Study in China

      hrp0098fc3.5
    • Adolescent Acne: Association to Sex, Age, Pubertal Stage and Circulating Concentrations of Testosterone and DHT

      hrp0098fc3.6
  • Adrenals and HPA Axis 1
  • • Real world data analysis of contemporary therapy and its association to anthropometric outcomes in 1500 patients with congenital adrenal hyperplasia (CAH)

      hrp0098fc4.1
    • 11-oxygenated androgens are abundantly produced by first and second-trimester foetal adrenal glands in ex vivo culture

      hrp0098fc4.2
    • Plasma reference values for C19 oxy-steroids, 11-keto testosterone and 11-keto androstenedione in a paediatric cohort

      hrp0098fc4.3
    • Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor (CRF₁) Antagonist, Reduced Excess Adrenal Androgens and Glucocorticoid Doses in Children and Adolescents with Classic Congenital Adrenal Hyperplasia: Results from CAHtalyst^TM Pediatric

      hrp0098fc4.4
    • 3D printed, personalized hydrocortisone for hypocortisolemia

      hrp0098fc4.5
    • Comparative Efficacy of Modified-Release versus Conventional Hydrocortisone Treatment in Adolescents and Young Adults with Congenital Adrenal Hyperplasia: A Retrospective Observational Study

      hrp0098fc4.6
  • Growth and Syndromes
  • • A homozygous variant in ZSWIM6 causes short stature, microcephaly and developmental delay

      hrp0098fc5.1
    • The pathogenesis of Noonan syndrome and associated growth restriction is modulated by NOC2L, a novel interactor of LZTR1 leading to impaired p53 signalling

      hrp0098fc5.2
    • Gene expression of monosomy × during human development reveals potential mechanisms in Turner syndrome

      hrp0098fc5.3
    • Predictors of short stature at age 6-7 years in Israeli children

      hrp0098fc5.4
    • Phase 2 Trial of Vosoritide Use in patients with Hypochondroplasia: Pharmacokinetic/ Pharmacodynamic analysis from 12 Month Data

      hrp0098fc5.5
    • First line treatment evaluation in patients with severe primary insulin-like growth factor 1 deficiency (SPIGFD): Data from the Global Increlex^® Registry

      hrp0098fc5.6
  • Fat, Metabolism and Obesity 1
  • • Corneal Nerve Loss and regeneration after GLP-1 Therapy in Children with Simple and Monogenic Obesity

      hrp0098fc6.1
    • Frequency of Bardet-Biedl syndrome variants in a population with early-onset obesity

      hrp0098fc6.2
    • SPISE is more strongly correlated with cardiometabolic factors in adolescents with obesity than HOMA-IR, and is related to the amount of body weight reduction under lifestyle intervention

      hrp0098fc6.3
    • Relaxation of Food Control Parameters Based on Improvements in the Food Safe Zone Questionnaire Occurs with Reduction of Hyperphagia in Clinical Trials of Diazoxide Choline Extended Release (DCCR) in Participants with Prader-Willi Syndrome

      hrp0098fc6.4
    • First cross sectional analysis of the eclip registry

      hrp0098fc6.5
    • Novel Melanocortin and Gut-peptide Dual Agonist for Obesity and Diabetes Treatment

      hrp0098fc6.6
  • GH and IGFs
  • • Clinical characteristics and response to growth hormone treatment in 27 children and adolescents with pathogenic NPR2 variants

      hrp0098fc7.1
    • Stratifying genetic etiology in children born small for gestational age with persistent short stature (SGA-SS): 5-year growth hormone (GH) treatment outcomes in genetic subgroups

      hrp0098fc7.2
    • Growth hormone (GH) deficiency and subsequent replacement therapy trigger differential expression of specific miRNAs in males and females: not just a matter of height

      hrp0098fc7.3
    • Growth Hormone Response to Glucagon Stimulation Test in Transitional Age

      hrp0098fc7.4
    • Use of overnight GH sampling in the diagnosis of growth disorders in children: neuroimaging findings and response to treatment

      hrp0098fc7.5
    • Growth, IGF-1 and IGFBP-3 Responses to Oral LUM-201 in OraGrowtH210 and OraGrowtH212 Trials in Pediatric Growth Hormone Deficiency (PGHD) over 12 to 24 Months on Treatment

      hrp0098fc7.6
  • Adrenals and HPA Axis 2
  • • Quantitative proteomics of pediatric adrenocortical tumors provides insights into zone of origin and identifies overrepresented pathways

      hrp0098fc8.1
    • Detection and differentiation of adrenocortical tumors (ACTs) in children by gas chromatography-mass spectrometry (GC-MS) based urinary steroid metabotyping

      hrp0098fc8.2
    • Insight into the role of TXNRD2 in steroidogenesis through a novel homozygous TXNRD2 splice variant

      hrp0098fc8.3
    • A deep intronic splice variant of CYP11B1 is the most common in Caucasian patients with 11-beta hydroxylase deficiency: functional, clinical and hormonal findings in 36 families

      hrp0098fc8.4
    • Free cortisol and free 21-deoxycortisol in the clinical evaluation of adrenal insufficiency in congenital adrenal hyperplasia

      hrp0098fc8.5
    • Plasma concentrations of renin and ACTH in children and adolescents from the general population: new reference intervals according to sex, age, and pubertal stage

      hrp0098fc8.6
  • Sex Endocrinology and Gonads
  • • A tiered approach to exome sequencing analysis in early-onset Primary Ovarian Insufficiency

      hrp0098fc9.1
    • Unveiling DHT-driven Androgen Receptor target genes in genital skin fibroblasts

      hrp0098fc9.2
    • Prenatal exposure to paracetamol is associated with reduced uterine volume at infancy - A COPANA Cohort study of 302 healthy girls

      hrp0098fc9.3
    • Prenatal exposure to paracetamol is associated with smaller testis volume and decreased levels of steroid metabolites during infancy in healthy males: A COPANA cohort study of 287 boys

      hrp0098fc9.4
    • Sex hormones shape the skeleton: The impact of puberty suppression and gender affirming hormone therapy on skeletal dimensions in transgender individuals

      hrp0098fc9.5
    • The Gender Identity Questionnaire for Children: a useful tool for gender identity detection in early life

      hrp0098fc9.6
  • Multisystem Endocrine Disorders
  • • Genetic screening and tumour surveillance program outcomes in rare paediatric hereditary endocrine tumour syndromes

      hrp0098fc10.1
    • Characterising the natural history of Multiple Endocrine Neoplasia 2B caused by M918T RET pathogenic variants in children and young people

      hrp0098fc10.2
    • Endocrine disorders in a wide cohort of children and adolescents affected by Neurofibromatosis type 1

      hrp0098fc10.3
    • A novel de novo SAMD9 gene variant causing MIRAGE syndrome associated with steroid-resistant nephrotic syndrome in a 46,XY male

      hrp0098fc10.4
    • Using sno-lncRNAs as potential markers for Prader-Willi syndrome diagnosis

      hrp0098fc10.5
    • Comprehensive analysis of disease spectrum and mortality in Sanjad-Sakati Syndrome: A Rare Disease Perspective

      hrp0098fc10.6
  • Fat, Metabolism and Obesity 2
  • • Frequency of rare syndromic diseases in a population with early-onset obesity

      hrp0098fc11.1
    • Frequency of rare non-syndromic diseases in a population with early-onset obesity

      hrp0098fc11.2
    • Asprosin serum levels in subjects with Prader-Willi Syndrome: associations with hyperphagia, anthropometric, and metabolic parameters

      hrp0098fc11.3
    • Long-term Efficacy Results of Diazoxide Choline Extended-Release (DCCR) Tablets in Participants with Prader-Willi Syndrome from the Completed C601 (DESTINY PWS) and C602 Open Label Extension (OLE) Studies

      hrp0098fc11.4
    • Complement 3 Alleviates Obesity Hypoventilation by Inhibiting Caspase-8/GSDME-Related Pyroptosis

      hrp0098fc11.5
    • Poly- and Perfluoroalkyl substances (PFAS) levels and breastfeeding have opposite associations with growth and body composition at age 3 years

      hrp0098fc11.6
  • Thyroid
  • • Use of targeted Next-Generation Sequencing panel in patients with non-autoimmune hypothyroidism: the experience of an Italian Pediatric Endocrinology Center

      hrp0098fc12.1
    • Molecular Characterization of Childhood Thyroid Nodules and Thyroid Cancer with DNA/RNA Next Generation Sequencing and Investigation of Phenotype-Genotype Correlation

      hrp0098fc12.2
    • Usefulness of application novel TurboTM TSAb bioassay in the monitoring of pediatric Graves’ patients

      hrp0098fc12.3
    • Docosahexaenoic acid (DHA) is reduced and could be protective against Hashimoto’s thyroiditis in children with Down syndrome: a cross-sectional study

      hrp0098fc12.4
    • The Association between Plasma Thyroxine Levels and Attention-Deficit/Hyperactivity Disorder

      hrp0098fc12.5
    • The First Robust Bioavailability/Bioequivalence (BA/BE) Study of Thyromimetic Tiratricol, a Treatment in Development for MCT8 Deficiency

      hrp0098fc12.6
  • Pituitary, Neuroendocrinology and Puberty 2
  • • Defect in C-terminal alpha-amidation during Kisspeptin synthesis: a new mechanism of hypogonadotropic hypogonadism

      hrp0098fc13.1
    • Copy Number Variation (CNV) in Self-limited Delayed Puberty (SLDP)

      hrp0098fc13.2
    • Effect of Precocious Puberty and GnRHa Treatment on Glucose Metabolism in Female Rats

      hrp0098fc13.3
    • Relationship between the timing of the physical changes of puberty and total pubertal growth in healthy adolescents: new insights which can provide helpful clinical guidance

      hrp0098fc13.4
    • Rising in body mass index during childhood in girls with idiopathic CPP: a 20-year experience in a tertiary Belgian centre

      hrp0098fc13.5
    • Voice frequency in healthy children and adolescents: A biomarker of androgen action in puberty

      hrp0098fc13.6
  • Fetal and Neonatal Endocrinology
  • • Non-invasive prenatal testing can detect maternally and paternally inherited variants in the KCNJ11 and ABCC8 genes: implications for clinical management of neonatal diabetes during pregnancy and beyond

      hrp0098fc14.1
    • Cord glucose: A normal reference and a potential of an ideal universal screening tool for pathological hyperinsulinism

      hrp0098fc14.2
    • Reduction of Overnight Hypoglycemia in Congenital Hyperinsulinism: Results from the RZ358-606 (RIZE) Study

      hrp0098fc14.3
    • Efficacy and Safety across Subgroups in Children with Congenital Hyperinsulinism Treated with Dasiglucagon

      hrp0098fc14.4
    • A novel 94bp deletion in the SLC16A1 promoter causes fasting and exercise-induced hyperinsulinaemic hypoglycaemia

      hrp0098fc14.5
    • Patient and Carer Perspectives: A National Survey of Continuous Glucose Monitoring in Children with Congenital Hyperinsulinism in the UK

      hrp0098fc14.6
  • Late Breaking
  • • Response to Daily and Weekly Recombinant Human Growth Hormone Treatment in Children Born Small for Gestational Age is Predicted More Accurately by Pre-treatment Blood Transcriptome than Clinical Variables

      hrp0098fc15.1
    • Amount and Pattern Of Pulsatile GH Secretion Induced By The Oral Growth Hormone Secretagogue LUM-201 Is Related To Growth And IGF-1 Responses In Moderate Pediatric Growth Hormone Deficiency (PGHD)

      hrp0098fc15.2
    • Assessment of actionable secondary genetic findings in a large cohort of children with short stature

      hrp0098fc15.3
    • Oral infigratinib for children with achondroplasia: Month 18 results from the PROPEL 2 study demonstrate safety and durability of treatment effect on linear growth with improved body proportionality

      hrp0098fc15.4
    • Presence of neuropathy in children and adolescents with type 1 diabetes evaluated with bedside modalities

      hrp0098fc15.5
    • Pharmacodynamic Endpoints After Once-Weekly Somapacitan in Children With GHD: 3-year results from REAL4 phase 3 study

      hrp0098fc15.6
• Rapid Free Communications
• • Diabetes and Insulin
  • • Perceptions and Experiences of PDSNs on Different Hybrid Closed Loop Systems (HCLS) across Wales

      hrp0098rfc1.1
    • Evaluating Glucose-6-Phosphate Dehydrogenase Enzyme Activity In Children With Type 1 Diabetes Mellitus

      hrp0098rfc1.2
    • Akkermansia muciniphila induces immune homeostasis in type 1 diabetic mice by up-regulating CD4 + FoxP3 + Treg expression

      hrp0098rfc1.3
    • Children born small for gestational age (SGA) under growth hormone treatment have similarly impaired glucose-insulin metabolism as children with obesity

      hrp0098rfc1.4
    • Evaluation of Arterial Stiffness in Children with Type 1 Diabetes Mellitus Using Speckle Tracking Carotid Strain Ultrasonography: Do Atherosclerotic Changes Begin in Childhood?

      hrp0098rfc1.5
    • Metabolic dysfunction-associated steatotic liver disease and its association with glycemic control metrics in children and adolescents with type 1 diabetes: an exploratory study

      hrp0098rfc1.6
  • Bone, Growth Plate and Mineral Metabolism
  • • Bone and Body Composition after one year of Vosorotide treatment in children with Achondroplasia: a longitudinal prospective study

      hrp0098rfc2.1
    • Microarchitectural Alterations in Children with Rheumatological conditions on Long term Glucocorticoid Treatment

      hrp0098rfc2.2
    • Optimizing the Growth Outcome follow up in Hypophosphatemic Rickets Treated with Burosumab: The Critical Role of Auxological Measurements

      hrp0098rfc2.3
    • CYP24A1 mutations: clinical and laboratory features in patients presenting with hypercalcemia

      hrp0098rfc2.4
    • Prediction of residual growth potential in adolescent boys by linear regression modeling based on the radiomics features extracted by knee DR images and clinical characteristics

      hrp0098rfc2.5
    • Comparison of two automated bone age evaluation methods in pediatric patients with growth and puberty disorders

      hrp0098rfc2.6
  • Pituitary, Neuroendocrinology and Puberty 1
  • • DNA Methylation profiles in girls with anorexia nervosa and amenorrhea: a pilot study

      hrp0098rfc3.1
    • Reduced central sensitivity to thyroid hormones in children and adolescents with overweight or obesity and impaired glucose tolerance

      hrp0098rfc3.2
    • Analysis of the expression levels of spexin and kisspeptin in serum, ovarian tissue and white adipose tissue as related to pubertal status and metabolic surrogates of puberty in female albino Wistar rats

      hrp0098rfc3.3
    • Longitudinal Changes in Serum DLK1 Concentrations During Pubertal Transition in Healthy Girls and in girls with Precocious Puberty during GnRHa treatment

      hrp0098rfc3.4
    • Long-Term Health Outcomes of Delayed Puberty in Males: A Comprehensive Population-Based Study

      hrp0098rfc3.5
    • Final Height and Endocrine Complications in Children with Pilocytic Astrocytomas: A Retrospective Study

      hrp0098rfc3.6
  • Adrenals and HPA Axis 1
  • • Screening for Adrenal Insufficiency in Children by Home Waking Salivary Cortisone testing

      hrp0098rfc4.1
    • Salivary cortisol and cortisone is related to age

      hrp0098rfc4.2
    • Differences and similarities in salivary diurnal adrenal hormones in monozygotic twins with intra-twin birthweight-differences

      hrp0098rfc4.3
    • Serum cortisol correlates strongly with salivary cortisol and cortisone in girls and boys, and across all ages

      hrp0098rfc4.4
    • Ontogenesis of the urinary steroid metabolome in infancy assessed by gas chromatography/mass spectrometry (GC-MS)

      hrp0098rfc4.5
    • Machine Learning-Based Decision Tree Model for the Diagnosis of Congenital Disorders of Adrenal Steroidogenesis Using LC-MS/MS-based Plasma Steroid Hormone Profiles

      hrp0098rfc4.6
  • Growth and Syndromes
  • • About caring for patients and understanding their pathways: 10 years of ‘the rotterdam centre for adults with rare genetic syndromes’

      hrp0098rfc5.1
    • The development and validation of Bone age-guided Interpretation of Growth (BIG), a web-based tool for the guidance of evaluation of children and adolescents with growth disorders

      hrp0098rfc5.2
    • Neuroradiological Findings in Noonan Syndrome: a multicentric Italian study

      hrp0098rfc5.3
    • Analysis of growth patterns in Klinefelter syndrome using the QEPS growth model

      hrp0098rfc5.4
    • Searching for associated dysmorphic and cardiac abnormalities in youth tall basketball players

      hrp0098rfc5.5
    • Pubertal induction in girls with Turner syndrome – retrospective data from the International TS registry

      hrp0098rfc5.6
  • Fat, Metabolism and Obesity 1
  • • Frequency of genetic variants in a population with early-onset obesity: a single center experience

      hrp0098rfc6.1
    • Genetic Diagnostic Yield of Obesity

      hrp0098rfc6.2
    • Identification and clinical characterization of new patients with novel monogenic agouti-like obesity trait

      hrp0098rfc6.3
    • Investigation of GNAS Variations as Causes of Monogenic Obesity in Qatar: An Integrative Approach Utilizing In Silico, In Vivo, and In Vitro Studies

      hrp0098rfc6.4
    • GRB10 methylation in umbilical cord associates postnatally with obesity in healthy children

      hrp0098rfc6.5
    • Potential role of aspg methylation as a biomarker of childhood obesity

      hrp0098rfc6.6
  • GH and IGFs
  • • Understanding the molecular basis of short stature in Fanconi Anemia: Impact of pappalysins and stanniocalcins on IGF-I bioavailability

      hrp0098rfc7.1
    • Time-Restricted Feeding Restored Growth Hormone Pulsatile Profile in LEAP-2 KO Mice with High Fat Diet

      hrp0098rfc7.2
    • Incidence of false positive results of growth hormone stimulation tests in children with short stature – from theoretical background to clinical approach

      hrp0098rfc7.3
    • Use of iSYS-IDS IGF1-Assay Normative Data as a STANDARD in the Diagnosis of Pediatric Growth Hormone Deficienc

      hrp0098rfc7.4
    • Health-related quality of life at mid-puberty in adolescents with idiopathic isolated growth hormone deficiency

      hrp0098rfc7.5
    • Big data as a strategy in the development of population auxological studies

      hrp0098rfc7.6
  • Adrenals and HPA Axis 2
  • • Predict – A randomized investigation of a reduced prenatal dexamethasone dose to reduce virilization in female fetuses with congenital adrenal hyperplasia

      hrp0098rfc8.1
    • A Novel Peroxisomal Cause of Primary Adrenal İnsufficiency: Pseudo-neonatal Adrenoleukodystrophy Due to ACOX1 Mutations

      hrp0098rfc8.2
    • Multi-hit Model of Primary Adrenal Insufficiency in CPOX mutations

      hrp0098rfc8.3
    • Rare Genetic Etiology of Primary Adrenal Insufficiency in Children; Clinical and Genetic Characterization of a Large Sudanese Cohort

      hrp0098rfc8.4
    • Mitochondrial Nicotinamide Nucleotide Transidrogenase (NNT) and NNT-AS1 impairment is associated with worse outcomes in patients with adrenocortical tumors

      hrp0098rfc8.5
    • Prospective evaluation of urinary outcome after partial urogenital sinus mobilization (PUM) for toilet trained female patients with classic congenital adrenal hyperplasia (CAH)

      hrp0098rfc8.6
  • Sex Endocrinology and Gonads
  • • Prenatal Steroid profiling in 46,XY Disorders of sexual Development (DSD) : A 10 year Retrospective Cohort study

      hrp0098rfc9.1
    • Effects of the modified release hydrocortisone preparation Efmody® on hormones, spermatogenesis and body weight in males with congenital adrenal hyperplasia

      hrp0098rfc9.2
    • Nanoencapsulated Curcumin-Piperine Complex: A Breakthrough in Targeting CYP17A1 for Managing Androgen Excess in Adolescents with PCOS

      hrp0098rfc9.3
    • Testicular function in prepubertal boys with haematological malignancies during and post chemotherapy: a prospective, longitudinal study

      hrp0098rfc9.4
    • Reevaluating Guidelines for Primary Ovarian Insufficiency Workup: Is It Time for a Change?

      hrp0098rfc9.5
    • GnRHa treatment of cryptorchidism alters testicular sumo gene expression

      hrp0098rfc9.6
  • Multisystem Endocrine Disorders
  • • Long-Term Endocrine Outcomes of Acute Lymphoblastic Leukemia Treatment with Special Emphasis on the Gonadal Impact

      hrp0098rfc10.1
    • Ten-year follow up for Children with non-lethal form of Raine Syndrome: Single Center Experience in Oman

      hrp0098rfc10.2
    • Anthropometric changes in survivors of childhood acute lymphoblastic leukemia treated on the Italian Association of Pediatric Hematology and Oncology protocols without radiotherapy in the last two decades: preliminary data from an Italian tertiary center

      hrp0098rfc10.3
    • Manifestation of PTEN and MUTYH gene mutations: A Case Report

      hrp0098rfc10.4
    • GAD-65 antibody positive autoimmune encephalitis with type III autoimmune polyendocrine syndrome: a rare pediatric case report

      hrp0098rfc10.5
    • Different Faces of Carney Complex: Report of Three Cases

      hrp0098rfc10.6
  • Fat, Metabolism and Obesity 2
  • • Assessing how the Edmonton Obesity Staging System for Pediatrics (EOSS-P) in childhood relates to later cardiometabolic health compared to other anthropometric measures of obesity

      hrp0098rfc11.1
    • Is the Single Point Insulin Sensitivity Estimator (SPISE) index a reliable tool for children and adolescents with overweight/obesity?

      hrp0098rfc11.2
    • Ultrasound evaluation of kidney and liver involvement in Bardet-Biedl syndrome

      hrp0098rfc11.3
    • Association of whole blood amino acid and acylcarnitine metabolome with anthropometry and IGF1 serum levels in healthy children and adolescents

      hrp0098rfc11.4
    • Hepatic lipogenesis increases FGF21 in children/adolescents with obesity

      hrp0098rfc11.5
    • Pten knockout in osteoprogenitor cells leads to loss of adipose tissue

      hrp0098rfc11.6
  • Thyroid
  • • From neurology to endocrine: Misdiagnosed MCT8 deficiency

      hrp0098rfc12.1
    • Prevalence and etiology of thyroid disorders and Characteristic of thyroid function tests in preterm infants

      hrp0098rfc12.2
    • Mechanisms and natural history of pituitary resistance to exogenous thyroxine in children with congenital hypothyroidism

      hrp0098rfc12.3
    • Establishing Outcomes and Management of Mild Neonatal Hyperthyrotropinaemia, a Retrospective Multi-Centre Review

      hrp0098rfc12.4
    • Use of the FT3/FT4 ratio as a predictor of relapse in autoimmune hyperthyroidism: retrospective study on a cohort of 80 pediatric patients

      hrp0098rfc12.5
    • Evaluation of thyroid nodules in children and adolescents by shear wave elastography (SWE)

      hrp0098rfc12.6
  • Pituitary, Neuroendocrinology and Puberty 2
  • • MRI-based radiomics of the pituitary gland is highly predictive of CentralPrecocious Puberty in girls: pilot study

      hrp0098rfc13.1
    • Novel anatomical quantification of all hypothalamic, pituitary, and stalk components predicts the severity of neuroendocrine phenotypes

      hrp0098rfc13.2
    • Unstimulated copeptin and oxytocin concentrations correlate with hypothalamic volumes and posterior pituitary location in congenital and acquired salt-water imbalance disorders

      hrp0098rfc13.3
    • Investigation of Pituitary Function in Langerhans Cell Histiocytosis: A Comprehensive Analysis of Clinical and Radiological Findings

      hrp0098rfc13.4
    • The Development and Validation of Bone-age guided Interpretation of Puberty, a web-based tool for guidance of pubertal disorders

      hrp0098rfc13.5
    • Hypogonadism hyperprolactinemia-related and its treatment in three patients with inherited disorders of biogenic amine metabolism

      hrp0098rfc13.6
  • Fetal and Neonatal Endocrinology
  • • The LIFE-MILCH project: preliminary data from the risk assessment model of exposure to Endocrine Disrupting Chemicals (EDCs) in mother-infant dyads during the first 3 months of life

      hrp0098rfc14.1
    • Does gestational diabetes mellitus influence mitochondrial dynamics in offspring?

      hrp0098rfc14.2
    • Complex Glycerol Kinase Deficiency: four new cases and a review of the literature

      hrp0098rfc14.3
    • Neurodevelopmental response to nifedipine treatment in an infant with Congenital Hyperinsulinism due to de novo gain-of-function CACNA1D variant

      hrp0098rfc14.4
    • The utility of ketones in screening for congenital hyperinsulinism: a retrospective evaluation

      hrp0098rfc14.5
    • Utility of Continuous Glucose Monitoring in hospital monitoring of patients with Hyperinsulinism

      hrp0098rfc14.6
  • Late Breaking
  • • Altered expression of epigenetic regulators is associated with high infertility risk in patients diagnosed with cryptorchidism

      hrp0098rfc15.1
    • Study on effects of poly- and perfluoroalkyl substances on hormones in girls with central precocious puberty

      hrp0098rfc15.2
    • The different faces of acquired hypothalamic dysfunction

      hrp0098rfc15.3
    • Autoimmunity in children with type 1 diabetes in association with the COVID_19 pandemic - results from the prospective DPV Registry

      hrp0098rfc15.4
    • Prevalence and management of modifiable cardiovascular risk factors among adolescents and young adults with type 1 diabetes – a cross-sectional analysis from the Diabetes Prospective Follow-Up Registry DPV

      hrp0098rfc15.5
    • Macrophage switch and iron metabolism regulation by Burosumab in XLH pediatric patients: implications in inflammation and pain modulation

      hrp0098rfc15.6
• Top 20 Posters
• • Top 20 Posters
  • • Genetic and Nutritional Influences on Growth: A Case of PAPPA2-Related Growth Disorder in a Pediatric Patient

      hrp0098t1
    • Comprehensive Evaluation of Anastrozole in Pediatric Height Management and Bone Health– A Real World Data

      hrp0098t2
    • Development and Validation of DSD Interpreter, a Mobile Application-Based Tool for Point-of-Care evaluation of Children with Atypical Genitalia

      hrp0098t3
    • More than 15 years of activity of the Ghent pediatric gender service: trends in referrals and medical steps

      hrp0098t4
    • Endocrine and metabolic complications after solid organ transplantation in childhood and adolescents

      hrp0098t5
    • Gonadal function in patients with germline variants of WT1: results from the French GONADVENIR’s retrospective study

      hrp0098t6
    • Long-read sequencing analysis in two Beckwith-Wiedemann syndrome families caused by defects of OCT4/SOX2 binding site

      hrp0098t7
    • Predicting the risk of fragility fractures in childhood hematologic cancer survivors

      hrp0098t8
    • Differential microRNA Expression Profiles in Girls with Central Precocious Puberty and Premature Thelarche

      hrp0098t9
    • Phenotypic and genotypic characterization and long-term follow-up of patients with thyroid hormone resistance

      hrp0098t10
    • Postnatal detection of sex chromosome abnormalities by quantitative fluorescence polymerase chain reaction – potential for newborn screening

      hrp0098t11
    • Investigating the Effects of Familial Mediterranean Fever on Growth and Puberty: Does the Duration of Puberty Change?

      hrp0098t12
    • Differential Impact of Maternal and Paternal Metabolic Syndrome on Offspring’s Cardiometabolic Risk Factors

      hrp0098t13
    • Alterations in BMI and Body Composition Twelve Months After Cessation of Growth Hormone Therapy in Adolescents with Prader-Willi Syndrome (PWS)

      hrp0098t15
    • The importance of genetic diagnosis in obesity - leptin-melanocortin pathway and beyond

      hrp0098t16
    • Burden of disease across age groups in individuals with hereditary hypophosphatemia – a retrospective Danish register study

      hrp0098t17
    • DNA methylation level at five specific CG-sites within TRAK1 correlates with the neurocognitive profile in individuals with Klinefelter syndrome

      hrp0098t18
    • Ultrasonographic Evaluation of Ovarian and Uterine Morphology in Minipuberty and Associations with Reproductive Hormones: A COPANA Cohort Study of 302 infant girls

      hrp0098t19
    • Real World Effectiveness of Vosoritide in 165 Children with Achondroplasia – Data from a Multicenter European Registry

      hrp0098t20
• Poster Category 1
• • Adrenals and HPA Axis 1
  • • Growth-promoting effect of adjuvant treatment in classic CAH 21OHD with impaired growth potential

      hrp0098p1-1
    • Reciprocal regulation of 11b-HSD1/2 correlates initial glucocorticoids responsiveness in childhood acute lymphoblastic leukemia

      hrp0098p1-2
    • Insulin-induced copeptin response in children and adolescents to diagnose arginine vasopressin deficiency* (*partly presented at the 61st Annual ESPE Meeting 2023)

      hrp0098p1-3
    • The Role of Endogenous Opioids (EOPs) in Ischaemic Pre-Conditioning (IPC) in Humans

      hrp0098p1-4
    • Evaluation of 2 years second tier testing for the screening on congenital adrenal hyperplasia (CAH)

      hrp0098p1-5
    • Impact of Fludrocortisone on Blood Pressure in Young Children Under 5 with CAH in the I-CAH Registry: Autoregressive Causal Inference Analysis

      hrp0098p1-6
    • Variation in Blood Pressure in Young Adults with 21a-Hydroxylase Deficiency: Longitudinal Multilevel Modelling of Data from the I-CAH Registry

      hrp0098p1-7
    • Leptin and adiponectin are associated with the glucocorticoid dose and androgen concentrations in children and young persons with congenital adrenal hyperplasia: data from the CAH-UK cohort

      hrp0098p1-8
    • Exploring the Long-Term Consequences of Congenital Adrenal Hyperplasia: First Study of Testicular Adrenal Rest Tumors Profile in Indonesia

      hrp0098p1-9
  • Bone, Growth Plate and Mineral Metabolism 1
  • • Causality between Sex Hormones and Bone Mineral Density in Childhood: Age- and Tanner stage-matched Sex Hormone Level May be an Early Interpreter of Pediatric Bone Fragility

      hrp0098p1-10
    • Clinical and genetic characteristics of primary hypoparathyroidism in children a multicenter experience in China

      hrp0098p1-11
    • X-linked hypophosphatemia caused by a novel deep intronic variant in the PHEX gene

      hrp0098p1-12
    • The Prevalence and Genotype-phenotype Correlation of Type E Brachydactyly in Chinese Children

      hrp0098p1-13
    • A Pilot Study on the Prevalence and Genetic Spectrum of Hypophosphatasia in Suzhou

      hrp0098p1-14
    • Adipokines level and vertebral fracture in children and adolescent with systemic lupus erythematous receiving glucocorticoid therapy

      hrp0098p1-15
    • A rare case of XLH with poor response to Burosumab: PHEX and SLC34A1 gene mutations

      hrp0098p1-16
    • New clinical phenotypes associated with ALPL mutations

      hrp0098p1-17
    • Vosoritide therapy in 16 young children with achondroplasia: a retrospective study

      hrp0098p1-18
    • Autosomal Dominant Hypocalcemia type 1 (ADH 1) with hypercalciuria due to CASR Ser820Phe mutation: a case report

      hrp0098p1-19
    • Cross-talk between mechanical loading and longitudinal bone growth under chronic inflammation

      hrp0098p1-20
  • Diabetes and Insulin 1
  • • A population preventive study of early detection of type 1 diabetes in asymptomatic children in the North-East region of Poland

      hrp0098p1-21
    • Clinical and molecular spectrum of polycystic kidney syndrome and diabetes due tomutations in hnf-1b

      hrp0098p1-22
    • Liraglutide potently protects against streptozotocin-induced acute islet injury by inhibiting HMGB1 release

      hrp0098p1-23
    • Associations between arterial stiffness and metabolic target in children and adolescents with type 1 diabetes treated in a modern setting

      hrp0098p1-24
    • Assessment of small nerve fiber function as an early marker of peripheral neuropathy in children and adolescents with type 1 diabetes mellitus (T1DM)

      hrp0098p1-25
    • Exercise induced hyperinsulinism as a rare cause of hypoglycaemia: A case report

      hrp0098p1-26
    • Insights into the Application of Molecular Genetics for Early Onset Diabetes Mellitus in a Prospective Pediatric Study

      hrp0098p1-27
    • Role of urinary tumor necrosis factor-alpha and transferrin in the diagnosis of diabetic nephropathy in pediatric patients with type 1 diabetes mellitus

      hrp0098p1-28
    • Wolcott-Rallison Syndrome: A Case Report of Novel Mutation

      hrp0098p1-29
  • Diabetes and Insulin 2
  • • The Impact of Sleep Quality and Metabolic Control in Children with Type 1 Diabetes: a Prospective Cohort Study

      hrp0098p1-30
    • Rare forms of (non)syndromic monogenic diabetes in the Czech registry of patients susceptible for monogenic diabetes

      hrp0098p1-31
    • Factors Associated with Pump Set Occlusion

      hrp0098p1-32
    • A Case of Mild Clinical Course MODY9

      hrp0098p1-33
    • Sexual knowledge and contraceptive use in adolescents with type 1 diabetes in comparison with their healthy peers

      hrp0098p1-34
    • Diabetes Mellitus in Woodhouse -Sakati syndrome

      hrp0098p1-35
    • Hair proteomics profile in girls with newly-diagnosed type 1 diabetes mellitus

      hrp0098p1-36
    • Influence of type 1 diabetes on age of menarche in girls with type 1 diabetes

      hrp0098p1-37
    • A Retrospective Analysis of Cost of Admission Care in Children with First Presentation of T1D at University Hospital Limerick: Assessing the Feasibility of Ambulatory Care

      hrp0098p1-38
  • Fat, Metabolism and Obesity 1
  • • The Effect of Excessive Fructose (Corn Syrup) Consumption on Insulin resistance, Lipid Profile and Lipid Peroxidation

      hrp0098p1-39
    • Detection of risk of non-alcoholic hepatic steatosis (nash) in obese children's population through rapid ultrasound measurement of preperitoneral abdominal fat “at the bed side”. a new strategy

      hrp0098p1-40
    • Prediction of hepatic fibrosis using the aspartate transaminase-to-platelet ratio index in children and adolescents with non-alcoholic fatty liver disease

      hrp0098p1-41
    • Unravelling the relationship between Head Circumference and Melanocortin4-Receptor deficiency from infancy to adulthood: a case-control study

      hrp0098p1-42
    • BIO-STREAMS: Multi-Pillar Framework for children Anti-Obesity Behavior building on an EU biobank, Micro Moments and Mobile Recommendation Systems

      hrp0098p1-43
    • Assessment of metabolomic-nutritional status and cardiovascular risk in adolescents with anorexia nervosa and low body weight

      hrp0098p1-44
    • EARLIE – Pilot study for universal familial hypercholesterolemia screening in Luxembourgish primary school children

      hrp0098p1-45
    • Circulating levels of ghrelin in patients with a rare disease with intellectual disability associated with hyperphagia, and/or overweight, and/or obesity – The HOGRID study

      hrp0098p1-46
    • Sleep quality and telomere length after long-term impact of a lifestyle intervention in patients with abdominal obesity

      hrp0098p1-47
    • Relationship between serum and faecal zonulin concentration and glucidic metabolism in children and adolescents with obesity

      hrp0098p1-48
  • GH and IGFs 1
  • • Correlations Between Nutritional Interventions, Growth Dynamics, and IGF-1 Levels in Pediatric Populations: A Comprehensive Analysis

      hrp0098p1-49
    • Genetic Variations in IGF1R and IGF1: Elucidating Their Role in Growth Disorders and Therapeutic Responsiveness

      hrp0098p1-50
    • The Metabolic Impacts of GH Therapy in SGA Children and Its Effects on Various Metabolic Parameters and Health Outcomes

      hrp0098p1-51
    • Changes in Length and Weight Standard Deviation Scores in Children with Growth Hormone Deficiency Across Various Studies

      hrp0098p1-52
    • Correlation of Growth Hormone Secretion and Infantile Growth Patterns in Children Diagnosed with Growth Hormone Deficiency (GHD)

      hrp0098p1-53
    • Should MRI Be Performed on the Pituitary Gland in Short Stature Children with Peak Growth Hormone Levels Between 5 and 7 Micrograms/Liter Following Provocation Tests?"

      hrp0098p1-54
    • The Relation Between Serum Glucose and Growth Hormone Concentrations During Standard Glucagon Test for GH Release in Short Stature Children

      hrp0098p1-55
    • Body composition abnormalities during the transition stage in males with growth hormone deficiency (GHD) after completion of replacement therapy

      hrp0098p1-56
    • Long-term treatment with recombinant human growth hormone in pediatric patients influences but does not destroy stem cells circulating in peripheral blood

      hrp0098p1-57
    • Somapacitan is Effective and Well Tolerated in Chinese Children with GHD: 52-week Results from the Randomized Phase 3 REAL6 Trial

      hrp0098p1-58
    • Near adult height in prepubertal children treated with growth hormone: differences between definite growth hormone deficiency (dGHD), short stature unresponsive to stimulation tests (SUS) and idiopathic short stature (ISS)

      hrp0098p1-59
  • Growth and Syndromes 1
  • • Big data tools for assessing the nutritional situation of a pediatric population: did the prevalence of obesity change pre- and post-pandemic?

      hrp0098p1-60
    • Comparison of the diagnostic yield of whole exome sequencing (WES) and targeted panel sequencing for children with idiopathic short stature (ISS)

      hrp0098p1-61
    • Aromatase inhibitors combined with rhGH treatment for idiopathic short stature in male adolescents Letrozole vs Anastrozole

      hrp0098p1-62
    • Long-term effectiveness and safety data from the Global Increlex^® Registry in patients treated with rhIGF-1: Subgroup analysis of naïve pre-pubertal patients and patients with Laron syndrome

      hrp0098p1-63
    • Osteocalcin in infancy and early childhood correlates to growth and body composition: A longitudinal birth cohort study

      hrp0098p1-64
    • Cardiovascular autonomic dysfunction and sleep abnormalities in children with Prader-Willi syndrome

      hrp0098p1-65
    • Turner Syndrome Across Karyotypes: The importance of the short arm of the X chromosome and Neutrophil-Driven Inflammatory Stress

      hrp0098p1-66
    • Study of genetic variability in a cohort of familial growth retardation

      hrp0098p1-67
    • Impact of Idiopathic Short Stature (ISS) on children’s well-being

      hrp0098p1-68
    • Hormonal markers of ovarian function and the role in predicting reproductive lifespan in girls with Turner syndrome

      hrp0098p1-69
  • Multisystem Endocrinology
  • • Two Cases of Type I Sialidosis and Literature Review

      hrp0098p1-70
    • Endocrine and metabolic comorbidities in juvenile-onset systemic lupus erythematosus

      hrp0098p1-71
    • Serum nesfatin-1 and GLP-1 concentrations in adolescent patients with anorexia nervosa/obesity

      hrp0098p1-72
    • A young patient with paraganglioma due to a novel SDHB gene pathogenic variant

      hrp0098p1-73
    • 10 Years’ experience in Omani cohort with variable presentation and genetically confirmed Wolfram Syndrome: Single Center Experience

      hrp0098p1-74
    • Endocrine Complications in Childhood Primary Brain Tumor Survivors: A Single Center Study

      hrp0098p1-75
    • The Significance of Clinical Examination in Diagnosing Genetic Diseases: An Infant with Williams-Beuren Syndrome

      hrp0098p1-76
    • An atypical presentation of McCune Albright syndrome

      hrp0098p1-77
    • The endocrine chameleon: expanding the phenotypic spectrum of pseudohypoparathyroidism 1A in infancy

      hrp0098p1-78
    • Clinical Characteristics and Management Outcomes in Girls with McCune-Albright Syndrome: An Experience from a Tertiary Center

      hrp0098p1-79
  • Pituitary, Neuroendocrinology and Puberty 1
  • • A 12-month, Open-Label, Single-Arm, Phase 3 Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty

      hrp0098p1-80
    • Changes of lipid and glucose metabolism indices in patients with transition growth hormone deficiency after rhGH replacement therap

      hrp0098p1-81
    • Comparative Analysis of α-Klotho Levels for the Diagnosis of Central Precocious Puberty (CPP) in Children: A Gender-Specific Study

      hrp0098p1-82
    • Frequency and phenotypic characteristics of copy number variations in patients with Kallmann syndrome and normosmic isolated hypogonadotropic hypogonadism

      hrp0098p1-83
    • Use of the arginine-stimulated copeptin test in paediatric polyuria-polydipsia syndrome: experience with eleven patients

      hrp0098p1-84
    • Do aromatase inhibitors used during adolescence affect male reproductive function in adulthood? An exploratory study

      hrp0098p1-85
    • Comprehensive study on central precocious puberty: molecular and clinical analyses in 90 patients

      hrp0098p1-86
    • Phenotypic characteristic of a large cohort of pediatrics Argentine patients with PSIS. High Prevalence of Mutations in ROBO1 gene

      hrp0098p1-87
    • Hypopituitarism following traumatic brain injury in children and adolescents - Long-term outcome study in a prospective patient cohort (2017-2023)

      hrp0098p1-88
  • Sex Endocrinology and Gonads 1
  • • Organokines and liver enzymes in adolescent girls with polycystic ovary syndrome during randomized treatments

      hrp0098p1-89
    • Decreased serum DHEAS to cortisol ratio in adolescents evaluated for gender dysphoria

      hrp0098p1-90
    • Serum steroid metabolite profiling by LC-MS/MS in two phenotypic male patients with HSD17B3 deficiency: implications for hormonal diagnosis

      hrp0098p1-91
    • Phenotypic spectrum of WT1 gene variants in DSD

      hrp0098p1-92
    • EuRRECa Core Registry: results from the Gender Incongruence module

      hrp0098p1-93
    • Comparative analysis of single cell RNA sequencing in Turner syndrome, female Graves’ disease patient, and normal female

      hrp0098p1-94
    • Phenotypes linked to duplication upstream of SOX9: New insights into presentation and diagnosis

      hrp0098p1-95
    • Study of the ovarian function and the gyneco-obstetrical profile of patients carrying a pathogenic variant of the HNF1B gene

      hrp0098p1-96
  • Thyroid 1
  • • Long term follow up of children with intrathyroidal ectopic thymus

      hrp0098p1-97
    • The Influence of multiple gene mutations on the continuation of levothyroxine therapy in patients with congenital hypothyroidism due to dyshormonogenesis

      hrp0098p1-98
    • Transient congenital hypothyroidism in a newborn with congenital goiter and compound heterozygosity for thyroglobulin

      hrp0098p1-99
    • Evaluating Malignancy in Pediatric Thyroid Nodules: The Effectiveness of the Bethesda System and TIRADS

      hrp0098p1-100
    • Genetic analyses in a cohort of pediatric patients with congenital hypothyroidism based on congenital hypothyroidism consensus guideline

      hrp0098p1-101
    • Diagnosis and treatment of a child affected with a novel thyroid hormone receptor alpha (thra) gene mutation

      hrp0098p1-102
    • The Relationship Between Antiepileptic Drug Use and Central and Peripheral Thyroid Hormone Sensitivity

      hrp0098p1-103
    • Thyroid nodules in children and adolescents: 26 years of experience in a large single academic center

      hrp0098p1-104
    • Presentation and outcome of ATA-Pediatric low-risk differentiated thyroid carcinoma (PLR-DTC) with high-invasive molecular alterations

      hrp0098p1-105
  • Adrenals and HPA Axis 2
  • • When Should We Consider Congenital Adrenal Hyperplasia in Children with Premature Pubarche: Key Features for Differential Diagnosis

      hrp0098p1-106
    • Non-invasive biochemical monitoring for Congenital Adrenal Hyperplasia: use of urinary steroid metabolites and salivary 17α-Hydroxyprogesterone

      hrp0098p1-107
    • Surveillance for phaeochromocytoma in children with changes in the SDHB gene may reduce morbidity: Contrasts in parent and child cases

      hrp0098p1-108
    • Prevalence of Adrenal Insufficiency in Patients with Nephrotic Syndrome: A Prospective Observational Study

      hrp0098p1-109
    • Does timing of Adrenocorticotropic hormone stimulation test matter?

      hrp0098p1-110
    • Investigating Changes in Plasma Aldosterone Concentrations Following ACTH Stimulation in Healthy Individuals: A Systematic Review and Meta-Analysis on the Influence of ACTH on Aldosterone Secretion

      hrp0098p1-111
    • Clinical characteristics and follow-up course of patients with 17α-hydroxylase/17,20-lyase deficiency in Korea: OUTSPREAD study

      hrp0098p1-112
    • A novel genetic variant in sphingosine-1-phosphate lyase causing primary adrenal insufficiency and inborn error of immunity

      hrp0098p1-113
  • Bone, Growth Plate and Mineral Metabolism 2
  • • IGF1R is most highly expressed in human iPS cell-derived proliferating chondrocytes: an approach to molecular mechanisms of IGF1 action in the human growth plate

      hrp0098p1-114
    • Unusual Presentation of Tumor-Induced Osteomalacia with Suppressed FGF-23 in an 8-Year-Old Boy

      hrp0098p1-115
    • Health related quality of life (HRQoL) of adolescents with XLH treated with burosumab at the end of skeletal growth (EoSG

      hrp0098p1-116
    • GH and Vosoritide combination: report of clinical experience in two girls with achondroplasia and GH deficiency

      hrp0098p1-117
    • Patient-Centred Data Collection Provides Comprehensive Insights into Healthcare Resource Use in Achondroplasia: Data From the Pilot Phase of the VIrtual STudy in Achondroplasia (VISTA)

      hrp0098p1-118
    • Craniometaphyseal Dysplasia Mimicking Infantile Osteopetrosis: A Case of Skeletal Hyperostosis and Calcipenic Rickets

      hrp0098p1-119
    • Health-related quality of life (HRQL) in paediatric patients with X-linked hypophosphatemia (XLH) in France: analysis of observational real-world registry data

      hrp0098p1-120
    • Lower Limb deformity in different types of rickets-A systematic literature

      hrp0098p1-121
    • Good response to bisphosphonate therapy in monozygotic twins with SCN8A mutations presenting with multiple fractures associated with seizures

      hrp0098p1-122
  • Diabetes and Insulin 3
  • • Severe Diazoxide-Unresponsive Congenital Hyperinsulinism Evolving to Diabetes in Early Adolescence Caused by a Homozygous p.(Cys26Tyr) ABCC8 Variant

      hrp0098p1-123
    • Comprehensive genetic analysis of Japanese patients with congenital hyperinsulinism

      hrp0098p1-124
    • Rising trend of type 2 diabetes following covid-19 pandemic in paediatric age group

      hrp0098p1-125
    • Non-invasive techniques to detect early signs and determinants of diabetic peripheral neuropathy in children with type 1 diabetes

      hrp0098p1-126
    • Molecular Characterization, Clinical phenotype and Long-Term Outcomes in Neonatal Diabetes Mellitus: nearly two decades of experience in a tertiary care pediatric diabetes clinic in north India

      hrp0098p1-127
    • Efficacy and safety of the tandem t:slim x2 with control-iq automated insulin inchildren with type 1 diabetes previously treated with multiple daily insulin injections

      hrp0098p1-128
    • Molecular and clinical profiles of pediatric monogenic diabetes subtypes: comprehensive genetic analysis by next-generation sequencing of 138 patients

      hrp0098p1-129
    • Evaluation of children with secondary diabetes; a single center study over a ten year-period

      hrp0098p1-130
    • Early Evaluation of 24-Hour Ambulatory Blood Pressure and Arterial Stiffness in Children with Type 1 Diabetes Mellitus for Protection of Vascular Health

      hrp0098p1-131
  • Fat, Metabolism and Obesity 2
  • • The proteome of circulating exosomes in appropriate- versus small-for-gestational-age infants: differentially expressed proteins at birth associate with measures of weight gain, liver fat, insulin resistance and adrenarche at age 7

      hrp0098p1-132
    • The effect of a lifestyle intervention program of diet, sleep and exercise on apelin-12, vaspin and resistin concentrations in children and adolescents with overweight and obesity

      hrp0098p1-133
    • The prevention of childhood obesity is a priority: preliminary results of the "EpPOI: Education to Prevent Childhood Obesity" project

      hrp0098p1-134
    • Genotype-phenotype correlation in Prader-Willi syndrome: A large-sample analysis in China

      hrp0098p1-135
    • PODiaCar-Fight against Pediatric Obesity: from a predictive tool for type 2 Diabetes and Cardiovascular diseases risk to healthy educational programs

      hrp0098p1-136
    • Evaluation of VEGF, MMP-9 and visfatin levels in adolescent girls with polycystic ovary syndrome and abdominal obesity

      hrp0098p1-137
    • Enhanced Metabolic Profiles Following Exercise Training in Children

      hrp0098p1-138
    • The effect of pharmacotherapy compared to lifestyle intervention on body composition in children and young people managed within a multidisciplinary weight management service

      hrp0098p1-139
    • Neither, Either or Both Parents with Metabolic Syndrome: Comparative Study of Its Impact on Sons and Daughters

      hrp0098p1-140
    • Assessment of Central Obesity and Body Mass Index in Youth Using a Non-Contact Radar Sensor

      hrp0098p1-141
  • Fat, Metabolism and Obesity 3
  • • The effect of a personalized, lifestyle intervention program on SFRP5 concentrations in children and adolescents with obesity

      hrp0098p1-142
    • Increased early cardiovascular risk in childhood brain tumor survivors

      hrp0098p1-143
    • Age different in anti-obesity treatment targeting BAT with Ang1-7

      hrp0098p1-144
    • Food deserts and deprivation: Experience from a Complications of Excess Weight Service in UK

      hrp0098p1-145
    • Evaluation of microvascular abnormalities and metabolic status in children with non-syndromic early-onset severe obesity using nailfold capillaroscopy

      hrp0098p1-146
    • Evaluation of Test Results According to Body Mass Index of Patients Who Had a GnRH Stimulation Test with a Preliminary Diagnosis of Precocious Puberty

      hrp0098p1-147
    • A novel homozygous frameshift mutation in ADCY3 in a consanguineous family with severe early-onset obesity

      hrp0098p1-148
    • Obstructive sleep apnea impairs insulin clearance and hepatic insulin sensitivity in children and adolescents with obesity

      hrp0098p1-149
    • Heterozygous Familial Hypobetalipoproteinemia: description of phenotype in affected children and adolescents in the Era of Obesityd

      hrp0098p1-150
    • An old disease: New problem. Why should pediatric endocrinologists recognize Wernicke's Encephalopathy due to thiamine deficiency?

      hrp0098p1-151
  • GH and IGFs 2
  • • Etiology of severe primary isolated growth hormone deficiency: a next-generation sequencing analysis of a single center cohort

      hrp0098p1-152
    • Enhancing growth hormone treatment adherence in Argentina: A patient support programme approach

      hrp0098p1-153
    • Growth chart with cut-offs for poor growth response to growth hormone therapy using worldwide data in patients with growth hormone deficiency and small for gestational age

      hrp0098p1-154
    • World-wide use of the Growzen™ Buddy smartphone app to improve adherence in patients receiving recombinant human growth hormone therapy

      hrp0098p1-155
    • Real-world adherence to growth hormone treatment and catch-up growth in children with growth disorders from the French SCOPE study

      hrp0098p1-156
    • The Long-Term Follow-up of Growth Hormone Treatment in a Case with 2q37 Deletion, 14q32 Duplication and Alopecia Totalis

      hrp0098p1-157
    • Tailoring the long-acting GH therapy in the real life

      hrp0098p1-158
    • Influence of GH and/OR IGF-1 concentrations on selected bone turnover markers in children with different short stature etiology

      hrp0098p1-159
    • Systematic Approach To Define Clinically Significant Variants of Unknown Significance (VUS) in Children With Short Stature

      hrp0098p1-160
    • Obesity/overweight – an unjustified obstacle to growth hormone treatment

      hrp0098p1-161
    • An attempt to establish cut-off points for GH concentration during the inhibition test based on the analysis of the test results performed in children without gigantism

      hrp0098p1-162
  • Growth and Syndromes 2
  • • Real-world utility of diagnostic gene panels for severe childhood growth failure and multiple pituitary hormone deficiency in the UK

      hrp0098p1-163
    • Prevalence of failure to thrive in infants with Prader-Willi syndrome and the long-term effects of GH-treatment

      hrp0098p1-164
    • A deep learning recognition model based on hand bone features for screening Turner syndrome

      hrp0098p1-165
    • Growth hormone therapy in patient with overlap syndrome: growth outcome after one year of treatment

      hrp0098p1-166
    • Familial Noonan Syndrome due to mutations in PTPN11 and PLOD1 genes

      hrp0098p1-167
    • Pubertal induction amongst girls with Turner Syndrome: oral vs patch oestrogen over the last 16 years

      hrp0098p1-168
    • Compliance in children with growth hormone deficiency treated with recombinant growth hormone (rhGH): a multicentre study in Poland

      hrp0098p1-169
    • Growth hormone therapy is not efficient in improving the adult height of children with Hypochondroplasia

      hrp0098p1-170
    • Referrals for short stature to a regional pediatric endocrinology referral: Similarities, trends, and variations in 780 children over 10 years

      hrp0098p1-171
    • Impact of Feeding Types on Catch-Up Growth in Early Infancy Among Small-for-Gestational-Age Infants: A Nationwide Korean Study

      hrp0098p1-172
  • Pituitary, Neuroendocrinology and Puberty 2
  • • Incidence of delayed puberty: A nationwide register-based study

      hrp0098p1-173
    • International Practice in Management of Puberty for Patients with Hypogonadotropic Hypogonadism

      hrp0098p1-174
    • Current Practice of Managing Hypogonadotropic Hypogonadism in Male Infants during Minipuberty – an International Survey

      hrp0098p1-175
    • Pelvic ultrasound and pubertal attainment in girls with sexual precocity: the pivotal role of uterine volume in predicting the timing of menarche

      hrp0098p1-176
    • Androgen Receptor Cag Repeat Polymorphism Might Be A Possible Cause of Familial Constitutional Delay in Growth and Puberty

      hrp0098p1-177
    • Investigation of the Emotional and Psychosocial Dimensions of Girls Diagnosed with Idiopathic Central Precocious Puberty

      hrp0098p1-178
    • A 31-year referral center experience in pediatric growth hormone secreting pituitary adenomas

      hrp0098p1-179
    • Retrospective Analysis of Pediatric Craniopharyngioma at a National Referral Center: A 37-Year Experience. Clinical Characteristics and Treatment Outcomes

      hrp0098p1-180
    • Characterization of puberty-regulating microRNAs within the hypothalamus of female mice

      hrp0098p1-181
  • Pituitary, Neuroendocrinology and Puberty 3
  • • A description of a national meeting for hypothalamo-pituitary-axis-tumours

      hrp0098p1-182
    • Arginine-stimulated copeptin for Central Diabetes Insipidus diagnosis in children

      hrp0098p1-183
    • Assessment of hypogonadotropic hypogonadism using a gonadotropic-gonadal stimulation test with subcutaneous Triptorelin: preliminary results

      hrp0098p1-184
    • Genetic analysis of a European cohort of ROHHAD patients

      hrp0098p1-185
    • Utility of First-Morning-Voided Urinary Total LH in Detecting the Onset of Central Puberty

      hrp0098p1-186
    • Moderate day-to-day variation in first morning urine total luteinizing hormone levels supports the use of a single determination to identify imminent puberty

      hrp0098p1-187
    • Childhood-onset craniopharyngioma: 26 years of experience at Children's Memorial Health Institute (CMHI)

      hrp0098p1-188
    • COVID-19 stressful conditions in the increase of central precocious puberty: long-term follow-up and timelines of this phenomenon demonstrate the declines to pre-pandemic levels after the end of online classes period in Italy

      hrp0098p1-189
    • The first description of an MC4R variant in a patient with Kallmann syndrome and obesity

      hrp0098p1-190
  • Sex Endocrinology and Gonads 2
  • • Assessing quality of care for people with differences of sex development (DSD) – results of an annual benchmarking of DSD centres in Germany

      hrp0098p1-191
    • Sex Steroid Metabolite Profile and Gonadotrophins during Hormone Therapy in Transgender Adolescents

      hrp0098p1-192
    • Under the Lens: A Study of Childhood Gender Identity Through the Toy Preference Test and its relation to minipuberty

      hrp0098p1-193
    • Consequences for treatment following the German Act on the Protection of Children with Differences in Sexual Development (DSD)

      hrp0098p1-194
    • Clitoromegaly - Size does matter

      hrp0098p1-195
    • Survey of pediatricians on the care provided to children with gender diversity

      hrp0098p1-196
    • 46 XY Gonadal Dysgenesis- Transmission of a Maternal Mosaic Novel DMRT1 Mutation

      hrp0098p1-197
    • Course and Predictors of Puberty in Boys with Isolated Micropenis

      hrp0098p1-198
  • Thyroid 2
  • • Novel compound heterozygous mutations in the SBP2 gene

      hrp0098p1-199
    • Severe congenital hypothyroidism due to a novel homozygous variant affecting the conserved CAGYC region of TSHβ

      hrp0098p1-200
    • Potential Role of Selected miRNAs in the Pathogenesis of Autoimmune Thyroid Diseases in Children and Adolescents

      hrp0098p1-201
    • Association between long-term exposure to fine particulate matter and onset of autoimmune thyroid diseases in children and adolescents: Evidence from a nationwide cohort study in Korea

      hrp0098p1-202
    • Experience with Combined T4 and T3 Therapy in Childhood Hypothyroidism

      hrp0098p1-203
    • Impact of the Presence of a Feeding Tube on Tiratricol Maintenance Dosing and Efficacy Outcomes in Patients with MCT8 Deficiency

      hrp0098p1-204
    • Treatment Outcomes in Pediatric Differentiated Thyroid Carcinoma: A Single Center Experience

      hrp0098p1-205
    • Usefulness of T4 measurement in neonatal screening for congenital hypothyroidism - Experience of two Italian Centers

      hrp0098p1-206
    • Newborn screening for congenital hypothyroidism and re-screening at two weeks of life in infants born to mothers with thyroid diseases

      hrp0098p1-207
  • Adrenals and HPA Axis 3
  • • The prevalence of nephrocalcinosis among patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency – one-centre experience. Do we need a regular screening?

      hrp0098p1-208
    • Early Childhood-Onset Non-Classical CAH (NCCAH) Presenting with Premature Pubarche and Clitoromegaly Caused by CYP21A2 Duplication Without Gene Mutation in Triplets

      hrp0098p1-209
    • Triple A syndrome: A common cause of primary adrenal insufficiency in Algeria

      hrp0098p1-210
    • Non tumoral ACTH-Independent Cushing Syndrome in Pediatric Patients: A Retrospective Observational Cohort Study

      hrp0098p1-211
    • Negative Impact of Supraphysiological Glucocorticoid Dosing on Growth and Changes in Glucocorticoid Dose and Androstenedione Health States in Patients with Classic Congenital Adrenal Hyperplasia: Results from the CAHtalog™ Patient Registry

      hrp0098p1-212
    • Prematurity and low birth weight may be key indicators for a low peak cortisol on neonatal Short Synacthen Tests

      hrp0098p1-213
    • The unique urinary steroid metabolome in infants with P450 oxidoreductase deficiency in the first week of life

      hrp0098p1-214
    • Who should be screened for electrolyte imbalances in the outpatient endocrinology clinic?

      hrp0098p1-215
  • Bone, Growth Plate and Mineral Metabolism 3
  • • Characterization of a large cohort of 99 argentinian patients with hereditary hypophosphatemic rickets (HHR) followed in a single pediatric tertiary center

      hrp0098p1-216
    • Preterm born young men have lower age and gender specific lumbar spine Z-scores compared to preterm born young women

      hrp0098p1-217
    • Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor Mutation: Experience with Cinacalcet and Parathyroidectomy

      hrp0098p1-218
    • Prospective longitudinal assessment of bone mineral density, circulating markers of bone turnover and changes in body composition in children and adolescents treated for acute lymphoblastic leukemia

      hrp0098p1-219
    • Safety and efficacy of continuous subcutaneous PTH (1-34) infusion therapy (CSPI) for severe autosomal dominant hypocalcaemia type 1 (ADH1) in Children and Young People (CYP)

      hrp0098p1-220
    • A 10-year non-interventional registry of patients with FGF23-related hypophosphatemic rickets and osteomalacia in Gulf Cooperation Council (GCC)

      hrp0098p1-221
    • Expanding the clinical phenotype of PKDCC Rhizomelic Skeletal Dysplasia – A Case Report and literature review

      hrp0098p1-222
    • Determinants of bone mineral density in healthy term-born children at age 6 months

      hrp0098p1-223
    • Rare diseases, rarely diagnosed: Mapping the accuracy of laboratory screening for rare bone disorders in Austria

      hrp0098p1-224
    • Lower Limb deformity in different types of rickets - A systematic literature review

      hrp0098p1-225
  • Diabetes and Insulin 4
  • • Microvascular complications of T1DM in children and adolescents at tertiary care hospital, pakistan

      hrp0098p1-226
    • Higher levels of c-peptide at the onset of Type 1 Diabetes are correlated with better glycemic control after 2 years from the diagnosis in a cohort of pediatric patients

      hrp0098p1-227
    • The use of pumps with Automated Insulin Delivery (HCL/AHCL) improves the Sleep Quality of Children and Adolescents with Type 1 Diabetes and of their parents/caregivers

      hrp0098p1-228
    • Nighttime Blood Pressure Disturbances in Children with Long-Term Type 1 Diabetes

      hrp0098p1-229
    • Screening for Dysglycaemia in Children Amidst a Global Obesity Crisis

      hrp0098p1-230
    • Children and Young People and Parent and Carer Perspectives on Provision of Type 2 Diabetes Mellitus Care in England and Wales – Insights from the PREM survey report (2021/22)

      hrp0098p1-231
    • Dietary interventions for the management of type 2 diabetes mellitus in childhood and adolescence: a systematic review

      hrp0098p1-232
    • Early Markers of Diabetic Nephropathy in Children and Adolescents with Type 1 Diabetes

      hrp0098p1-233
  • Fat, Metabolism and Obesity 4
  • • Diploid/triploid mosaicism: a rare cause of metabolic syndrome and diabetes in children

      hrp0098p1-234
    • Towards a “Genetic Obesity Risk Score”: preliminary data from a single-centre cohort of obese children and adolescents

      hrp0098p1-235
    • Prevalence of variants in the Leptin Melanocortin 4 receptor (MC4R) pathway in an Israeli cohort of children with severe obesity and their clinical and laboratory characteristics

      hrp0098p1-236
    • Health transition of children with obesity - a comprehensive approach from a German obesity center: a prospective cohort analysis

      hrp0098p1-237
    • Predictive Value of Impulse Oscillometry and Hepatic Fat Content for Obstructive Sleep Apnea Syndrome in Obese Children and Adolescents

      hrp0098p1-238
    • Evolution of the cytokine profile following duodenal-jejunal bypass liner in adolescents with obesity

      hrp0098p1-239
    • Patient and parent experience of a group exercise programme collaboration with a tertiary paediatric weight management service

      hrp0098p1-240
    • Genetics of obesity: results from a tertiary paediatric weight management service

      hrp0098p1-241
    • GNAS mutation: an under-rated cause of severe early-onset obesity!

      hrp0098p1-242
  • Fetal and Multisystem Endocrinology
  • • Experience with Cinacalcet in Neonatal Severe Hyperparathyroidism Due to CASR Mutation

      hrp0098p1-243
    • Tear proteomics in children and adolescents with congenital hyperinsulinism

      hrp0098p1-244
    • The LIFE-MILCH study: first data on the exposure to Endocrine Disrupting Chemicals (EDCs) in urine and breast milk (BM) from end of pregnancy to 12 months of life

      hrp0098p1-245
    • Rarity of congenital adrenal hyperplasia in children born verypreterm: Possible mechanism and implication for newborn screening

      hrp0098p1-246
    • Congenital hyperinsulinism (mutation in GCK gene) and congenital hypothyroidism in one of the monozygotic twins

      hrp0098p1-247
    • Assessment of carbohydrate and lipid metabolism in patient with glycogen storage disease type 0a and celiac disease at diagnosis and after 3 years of follow-up - case report

      hrp0098p1-248
    • The prevalence of thyroid disorders and coeliac disease in children wih type 1 diabetes mellitus seen in a tertiary hospital in resource limited setting

      hrp0098p1-249
    • In an era of advanced genomic testing- is karyotype still relevant?

      hrp0098p1-250
    • The Use Of EQ5D For Assessment Of Health Related Quality Of Life And Its Determinants In Children With Complex Endocrine Conditions

      hrp0098p1-251
  • Growth and Syndromes 3
  • • Growth Hormone Therapy in Prader Willi Syndrome – Audit of Age of Initiation Over Time in a Tertiary Centre

      hrp0098p1-252
    • Establishing a Nurse-led Transition Clinic for Young People with Congenital Adrenal Hyperplasia (CAH): Quality Improvement Project

      hrp0098p1-253
    • Growth Response to Medical Intervention in an Observational Real-life Study of Children with Growth Delay: A Causal Inference Method

      hrp0098p1-254
    • Health and life risks in children with achondroplasia – multicenter study

      hrp0098p1-255
    • Height outcomes in children born small for gestational age (SGA) from combined CrescNet and REPAR cohorts: The impact of either spontaneous or growth hormone-induced catch-up growth

      hrp0098p1-256
    • Molecular and phenotypic characteristics of chinese neurofibromatosis type 1 children

      hrp0098p1-257
    • First Real-Life Data on the Use of Long-Acting Growth Hormone Somatrogon in Türkiye

      hrp0098p1-258
    • Polysomnography Findings and Respiratory Problems in Prader-Willi Syndrome: The Effect of Growth Hormone Treatment

      hrp0098p1-259
    • Long-Acting Growth Hormone Therapy in Children with Growth Hormone deficiency – A two centre real world experience from UK

      hrp0098p1-260
    • Recombinant Growth Hormone Therapy in Pediatric Renal Failure: 30-Year-Experience in a Tertiary Hospital

      hrp0098p1-261
  • Growth and Syndromes 4
  • • A novel comprehensive bioinformatic strategy could significantly enhance the molecular genetic diagnosis in growth restriction phenotypes

      hrp0098p1-262
    • Reduced final height in boys after allogeneic hematopoietic stem cell transplantation (HSCT) for childhood cancer: does pubertal growth spurt matters?

      hrp0098p1-263
    • Single center prospective study on the Efficacy and Safety of Vosoritide Therapy in Achondroplasia: A Comprehensive Evaluation at Three and Six Months

      hrp0098p1-264
    • Use of Vosoritide in Children with Achondroplasia - Real Life Experince

      hrp0098p1-265
    • AFMS (Achondroplasia Foramen Magnum Score) in a case series; correlation with clinical manifestations, and sleep studies

      hrp0098p1-266
    • The clinical burden and healthcare resource utilization among children and adolescents with achondroplasia: an observational cohort study using Optum’s de-identified Clinformatics^® Data Mart Database

      hrp0098p1-267
    • Mechanisms of Growth Failure in a Mouse Model of Aggrecan Deficiency: Insights into Chondrocyte Function and Akt Signaling

      hrp0098p1-268
    • Effect of treatment with Isotretinoin on early bone maturation: A Case Report

      hrp0098p1-269
    • Expression levels of serum AMH and INHB in children with different karyotypes of Turner syndrome and assessment of their ovarian reserve function

      hrp0098p1-270
  • Pituitary, Neuroendocrinology and Puberty 4
  • • The Use Of GloBE-Reg As A Global Platform For Performing Safety & Efficacy Studies Of rhGH Therapy

      hrp0098p1-271
    • Nonfunctioning pituitary adenomas in childhood: A single-center experience

      hrp0098p1-272
    • Prospective assessment of hypothalamic dysfunction (HD) in congenital or tumorous diseases and impact on quality of life

      hrp0098p1-273
    • Somatotropinomas in Pediatric Endocrinology Practice: Single Center Experience

      hrp0098p1-274
    • Endocrine Deficiency after Photon and Proton Radiotherapy for Medulloblastoma in Hokkaido University Hospital, Japan

      hrp0098p1-275
    • Associations Among Clinical, Hormonal, and Imaging Data with Developmental Outcomes in Congenital Combined Pituitary Hormone Deficiency: A National Multicenter Retrospective Study

      hrp0098p1-276
    • A rare cause of hypogonadotropic hypogonadism: KLB gene variant in a prepubertal boy evaluated for micropenis

      hrp0098p1-277
    • Water deprivation test in children: challenging but still necessary to diagnose central diabetes insipidus

      hrp0098p1-278
    • Value of serum AMH and INHB in the diagnosis and treatment of central precocious puberty and early and fast puberty girls

      hrp0098p1-279
  • Sex Endocrinology and Gonads 3
  • • Validation Of A New Short Parent Reported Outcomes (PRO) Questionnaire For Boys With A Condition Affecting Sex Development (CSD)

      hrp0098p1-280
    • Comparison between, clinical, metabolic and hormonal parameters and selected microRNAs in adolescent girls with PCOS and healthy controls

      hrp0098p1-281
    • Estrogen and progesterone in immune dysfunction at childhood follow up of preterm infants

      hrp0098p1-282
    • Care in the first weeks after a suspected DSD diagnosis – results of the Empower-DSD information management program

      hrp0098p1-283
    • Face processing patterns in individuals with gender incongruence or differences of sex development: an eye-tracking study

      hrp0098p1-284
    • A Little Known But Very Common Phenotype in Patients with Congenital Neutropenia Due to HAX1 Deficiency: Premature Ovarian Failure

      hrp0098p1-285
  • Thyroid 3
  • • Has COVID-19 Changed Pediatric Graves' Disease? A Study Investigating Post-Pandemic Trends

      hrp0098p1-286
    • Abstract unavailable

      hrp0098p1-287
    • Assessment of regulatory B cells in peripheral blood and zinc transporter 8 expression in thyroid tissue in children with autoimmune thyroid diseases

      hrp0098p1-288
    • Papillary thyroid cancer in a teenager with thyroid hormone resistance syndrome: features of postoperative management

      hrp0098p1-289
    • A Retrospective Observational Study of Patients with Differentiated Thyroid Cancer from a Pediatric Endocrinology Clinic in Crete

      hrp0098p1-290
    • Response to TRIAC therapy in a child with Resistance to Thyroid Hormone beta and behavioural abnormalities

      hrp0098p1-291
    • Congenital autoimmune thyreoiditis with hypothyroidism: first expression of a STAT-3-associated multisystemic disease with further severe autoimmune manifestations

      hrp0098p1-292
    • Genetic Etiology in Congenital Hypothyroidism

      hrp0098p1-293
  • Late Breaking 1
  • • Prolacrin associates to adrenal androgens during adrenarche

      hrp0098p1-294
    • GC-MS urinary steroid metabolome reveals substantial dysregulation of adrenal, gonadal, and neuroactive steroids in adolescents with depressive symptoms

      hrp0098p1-295
    • Evaluating Setmelanotide Treatment for 12 Months in Pediatric Age Groups With Rare Melanocortin-4 Receptor Pathway–Related Obesity: Efficacy in Weight Reduction and Safety Outcomes

      hrp0098p1-296
    • Three-year results on weight and eating disorders with digi-physical treatment in paediatric obesity: A pragmatic clinical trial

      hrp0098p1-297
    • The severity and correlates of depressive symptoms in adolescents with obesity compared to normal adolescents in Hong Kong using a validated Patient Health Questionnaire-9 screening tools

      hrp0098p1-298
    • A Real-World Pharmacovigilance Assessment and Literature Review of Lymphoma Development in Lipodystrophy and Congenital Leptin Deficiency

      hrp0098p1-299
    • The Diagnostic and Therapeutic Monitoring Value of Morning Urinary Gonadotropins for Central Precocious Puberty in Girls with Different BMI

      hrp0098p1-300
    • The incidence of central precocious puberty and the effect of BMI (real-world data In Korea)

      hrp0098p1-301
    • Evaluation of Copeptin Level in Children and Adolescents Monitored with Central Diabetes Incipidus

      hrp0098p1-302
    • Treating Arginine Vasopressin Deficiency in Infants is a Challenging Condition: A 20-year Single-Center Study

      hrp0098p1-303
  • Late Breaking 2
  • • ER stress relief drives ß-cell proliferation

      hrp0098p1-304
    • Lipodystrophy severity score improves in patients with generalized lipodystrophy following metreleptin treatment

      hrp0098p1-305
    • Role of Cubulin gene variants in the development of microalbuminuria in children with type1 diabetes

      hrp0098p1-306
    • The man in the LOOP: Ramadan fast in Type 1 diabetic patients with a Closed Loop automated insulin delivery system

      hrp0098p1-307
    • Empowering diabetes self-management and peer connections – The role of a community young adult diabetes specialist nurse (CODSN) and diabetes youth worker (YW) in improving outcomes, Transition Safe and Sound (TraSS), an NHS England pilot

      hrp0098p1-308
    • Safety and efficacy of efpegerglucagon in patients with congenital hyperinsulinism: interim results from a phase 2 study

      hrp0098p1-309
    • The iPhone Measure app as a measuring device for the height in pediatrics: a reliability study

      hrp0098p1-310
    • Heterozygous PLAG1 gene variants causing Silver-Russell syndrome in a case series of 4 patients

      hrp0098p1-311
    • SGPL1 deficiency is associated with reduced lipid droplet formation and impaired steroidogenesis in Leydig cells

      hrp0098p1-312
    • Do We Need Seasonal Thyroid Hormone Reference Values in Pediatric Endocrinology? Results from a Population-Based Study

      hrp0098p1-313
• Poster Category 2
• • Adrenals and HPA Axis
  • • Compromised linear growth and Final adult height in children with classic CAH 21OHD

      hrp0098p2-1
    • ESPE School: Sharing Knowledge to Save Lives - Developing and Standardizing Education for Healthcare Providers and Families with Children with Adrenal Insufficiency in Kazakhstan

      hrp0098p2-2
    • The Impact of the COVID-19 Pandemic on Patients with Adrenal insufficiency

      hrp0098p2-3
    • Pitfalls in diagnosis of Congenital Adrenal Hyperplasia due to 3beta-hydroxysteroid dehydrogenase type 2 (HSD3B2) deficiency – A Problem of Assay Interference

      hrp0098p2-4
    • Pharmacological therapy of adrenal hypercortisolism in a boy with suspected isolated micronodular adrenal hyperplasia (iMAD) due to a mutation in the PDE11A gene

      hrp0098p2-5
    • Diagnosis of Cushing's Disease with Desmopressin-Induced Bilateral Inferior Petrosal Sinus Sampling: A Case Report

      hrp0098p2-6
    • ESPE Caucasus&Central Asia School (C&CAS) Sharing Knowledge for Saving Patients' Lives: Organizing pediatric endocrinology care for patients with adrenal insufficiency in Armenia

      hrp0098p2-7
    • Missed Diagnosis of Triple A Syndrome in a Syrian 3 year-old boy in Lebanon

      hrp0098p2-8
    • The Role of Midkin and Inflammatory Cytokines in The Pathophysiology of Metabolic Syndrome in Children and Adolescents with Classical Congenital Adrenal Hyperplasia Due to 21 Hydroxylase Enzyme Deficiency

      hrp0098p2-9
    • Early Diagnosis of Adrenoleukodystrophy in Two Siblings

      hrp0098p2-10
    • Iatrogenic adrenal insufficiency – a single centre response to increasing awareness and instituting management in non-endocrine specialities

      hrp0098p2-11
    • Central adrenal assessment in a group of prepuberal Prader Willi Syndrome patients in a tertiary center

      hrp0098p2-12
    • X-linked adrenoleukodystrophy in two male siblings; Endocrinological aspects of the disease, and therapeutic approaches

      hrp0098p2-13
    • Clinical characteristics of rare forms of paediatric congenital adrenal hyperplasia (CAH) in a single tertiary centre

      hrp0098p2-14
    • Premature Adrenarche, Body Composition and Metabolic Dysfunction – Characterisation of a Pilot Cohort

      hrp0098p2-15
    • The challenge of diagnosis and management of micronodular adrenocortical disease in a 7-year old girl with cyclic cushing syndrome: a case report

      hrp0098p2-16
    • 17OHP and cortisol day curve profiles for children using hard-capsule modified release hydrocortisone as compared with immediate release hydrocortisone

      hrp0098p2-17
    • Determination of Anti-Müllerian Hormone and Inhibin B Reference Ranges According to Pubertal Stages in Children and Adolescent Girls

      hrp0098p2-18
    • Metabolic risk factors in children with Premature Adrenarche – a systematic review and meta-analysis

      hrp0098p2-19
    • Clinical spectrum and outcome of adrenocortical tumours in children

      hrp0098p2-20
    • Should we routinely screen for adrenal rests in Congenital Adrenal hyperplasia?

      hrp0098p2-21
    • Severe Adrenocortical Carcinoma Presentation with Vena Cava Involvement in a 1-Year-Old Boy: A Case Presentation and Management Considerations

      hrp0098p2-22
    • Adrenal Lesions Evaluated in A Pediatric Endocrinology Department

      hrp0098p2-23
    • Genotype-Phenotype correlations in three patients with CYP21A2 picked up by 17- ɑ OHP screening

      hrp0098p2-24
    • X-linked congenital adrenal hypoplasia due to a novel mutation in NR0B1 gene

      hrp0098p2-25
  • Bone, Growth Plate and Mineral Metabolism
  • • Bisphosphonate Therapy in a Pediatric Case Series with Monostotic Form of Fibrous Dysplasia: A Single-Center Retrospective Analysis of Efficacy and Safety

      hrp0098p2-26
    • Infantile hypercalcemia with CYP24A1 variant triggered by fortified milk

      hrp0098p2-27
    • HDR syndrome due to a new mutation in the GATA3 gene

      hrp0098p2-28
    • Vitamin D dependent rickets Type 2A: A case series of two siblings with novel mutation in vitamin D receptors responded to high dose oral calcium and calcitriol

      hrp0098p2-29
    • Investigation of GNAS Gene Mutation and Clinical Correlations in Patients Followed with the Diagnosis of Pseudohypoparathyroidism

      hrp0098p2-30
    • Bisphosphonates: A promising treatment for osteolytic lesion in Langerhans cell histiocytosis

      hrp0098p2-31
    • A rare presentation of parathyroid adenoma as bilateral genu valgum in an adolescent Pakistani girl

      hrp0098p2-32
    • Dysplasia Epiphysealis Hemimelica combined with Familial Hypocalciuric Hypercalcemia – can the calcium-sensing receptor have a role in expansive bone lesions?

      hrp0098p2-33
    • Persistent Hypocalcemia In a Pakistani Infant: A Rare Activating CaSR Mutation

      hrp0098p2-34
    • Tibial-tubercle avulsion and patellar-tendon rupture in an adolescent with osteogenesis imperfecta

      hrp0098p2-35
    • KIF22 Mutation with Spondyloepimetaphyseal Dysplasia with Joint Laxity, Leptodactylic Type 2 (SEMDJL2)

      hrp0098p2-36
    • Vosoritide Therapy in Children with Achondroplasia: Single-Center Experience

      hrp0098p2-37
    • Kenny-caffey syndrome in the neonatal period

      hrp0098p2-38
    • PTHLH gene mutation: A rare diagnosis of skeletal dysplasia

      hrp0098p2-39
    • An adolescent health care clinic at King Abdulaziz Medical City, Jeddah, Saudi Arabia

      hrp0098p2-40
    • Linear growth in children and adolescents treated with zoledronic acid (ZA): A Single Institution Case Series

      hrp0098p2-41
    • The etiological distribution of elevated serum alkaline phosphatase levels and characteristics of children with transient hyperphosphatasemia

      hrp0098p2-42
    • The development of low selenium concentrations in children undergoing liver transplantation

      hrp0098p2-43
    • Use of denosumab in aneurysmal bone cyst and giant cell tumor in a third-level pediatric center

      hrp0098p2-44
    • Hereditary hypophosphatemic rickets with hypercalciuria: a rare disorder not to be forgotten about

      hrp0098p2-45
    • Advanced bone age in short stature due to ACAN gene mutation: a case report

      hrp0098p2-46
    • Evaluation of Pediatric Cases with ACAN Gene Variants

      hrp0098p2-47
    • Two likely compound heterozygous variants in SLC34A1 causing idiopathic infantile hypercalcemia (IIH) type 2 - a case report

      hrp0098p2-48
    • A case of parathyroid carcinoma in a pediatric patient

      hrp0098p2-49
    • Lysinuric Protein Intolerance: A Case Report of a Child Presenting with Multiple Fractures to Bone Clinic

      hrp0098p2-50
    • Real-world experience with vosoritide treatment in achondroplasia: A single-center report from Turkey

      hrp0098p2-51
    • Current challenges in diagnosis, treatment, and follow-up of children with parathyroid hormone dysfunction – lessons learned from a cohort of children presenting with hypocalcaemia

      hrp0098p2-52
    • Bone mineralization at around age 5 years in children born very preterm compared to children born term

      hrp0098p2-53
    • The clinical burden and healthcare resource utilization among children and adolescents with osteogenesis imperfecta: an observational study using Optum’s de-identified Clinformatics^® Data Mart Database

      hrp0098p2-54
    • Bone Mineral Density in Children with Inflammatory Bowel Disease

      hrp0098p2-55
    • Real-world effectiveness of vosoritide in children with achondroplasia: Results from 18 months follow-up in France

      hrp0098p2-56
  • Diabetes and Insulin
  • • Sleep disturbances in children and adolescents with type 1 diabetes mellitus: Prevalence, and relationship with diabetes management

      hrp0098p2-57
    • The Relationship of Serum Diabetes Antibodies with the Development of Early Diabetic Retinopathy Findings in Children with Type 1 Diabetes Mellitus

      hrp0098p2-58
    • Impact of Telemonitoring on Glycemic Control in Pediatric Patients with Type 1 Diabetes Mellitus

      hrp0098p2-59
    • The incidence of type 1 diabetes among estonian children in 2007-2022 in comparison with the data from 1983 to 2006 and the impact of the covid-19 pandemic

      hrp0098p2-60
    • A Novel Disease-causing Variant of INS-MODY with a Unique Phenotype

      hrp0098p2-61
    • Founder WSF1 Mutation Causing Wolfram Syndrome in the Druze Population in Israel

      hrp0098p2-62
    • The frequency of anemia and the evaluation of related factors in patients with type 1 diabetes mellitus

      hrp0098p2-63
    • Hybrid closed loop systems: are they all the same? 1-year of follow-up outcomes of two hcls in children with type 1 diabetes: a real-life based study

      hrp0098p2-64
    • Diabetes mellitus, macrocytosis and skin pigmentation disorder in a child with large-scale mtdna deletion

      hrp0098p2-65
    • Genetic analysis and treatment of congenital hyperinsulinemic hypoglycemia: A single center's experience

      hrp0098p2-66
    • Clinical Outcomes with MiniMedTM 780G Advanced Hybrid Closed-Loop Therapy In Children <7 years with Type 1 Diabetes

      hrp0098p2-67
    • Evaluation of the relationship between glucose levels and oxidative stress through ischemia-modified albumin levels during oral glucose tolerance test

      hrp0098p2-68
    • Venous Sodium, Potassium, and Glucose Results on Rapid Arterial Blood Gas Analyzer in Children with Diabetic Ketoacidosis: Are the Values Comparable with Results Obtained from the Central Laboratory?

      hrp0098p2-69
    • Efficacy of Advanced Hybrid Closed-Loop System Medtronic MiniMed™ 780G in Japanese children with type 1 diabetes mellitus (T1DM)

      hrp0098p2-70
    • Severe Acute Kidney Injury in an Adolescent with Diabetic Ketoacidosis

      hrp0098p2-71
    • Neonatal Diabetes, Thrombocytopenia, and Atopic Dermatitis: A Diagnostic Challenge of IPEX Syndrome

      hrp0098p2-72
    • Neonatal Diabetes Due to Insulin Gene Mutation

      hrp0098p2-73
    • Incidence and modes of presentation of childhood type 1 diabetes mellitus in Malta between 2012 and 2023

      hrp0098p2-74
    • Rabson Mendenhuall Syndrome: the phenotype, genotype and management in a cohort of Sudanese children

      hrp0098p2-75
    • Severe hypertriglyceridemia: a rare but serious complication of diabetic ketoacidosis in children

      hrp0098p2-76
    • Congenital Generalized Lipodystrophy in Down Syndrome patient

      hrp0098p2-77
    • Permanent Neonatal Diabetes in Kosova, incidence, genetics, clinical phenotype and treatment

      hrp0098p2-78
    • Linking diabetes and severe cardiac malformations: a GATA6 mutation

      hrp0098p2-79
    • Influence of SARS-COV-2 virus on initial manifestation of type 1 diabetes in children: national data from latvia

      hrp0098p2-80
    • “Sweet” lies detector; Factitious Diabetes Mellitus as a rare presentation of Munchausen by Proxy syndrome

      hrp0098p2-81
    • Investigating the Confidence and Training needs of the Wythenshawe Hospital Emergency Department Clinicians in the Management of Paediatric Type 1 Diabetic Emergencies

      hrp0098p2-82
    • Phenotypic Spectrum at Diagnosis of Age-Related Endotypes of Type 1 Diabetes Mellitus: A Cross-Sectional Study in China

      hrp0098p2-83
    • Endocrine Evaluation in Patients with Cystic Fibrosis: A Retrospective Study from Single Tertiary Center

      hrp0098p2-84
    • Clinical Characteristics and follow-up of Type 2 Diabetes in Children and Adolescents: A Single Center Experience

      hrp0098p2-85
    • Endotypes in diabetes, different diabetes, different management?

      hrp0098p2-86
    • Interim analysis of the prospective evaluation of putatively influential factors associated with the timing and duration of honeymoon phase in newly diagnosed pediatric patients with Type 1 Diabetes

      hrp0098p2-87
    • Effectiveness of Different Insulin Delivery Systems Among Preschool Children with Type 1 Diabetes

      hrp0098p2-88
    • Testing a new “accelerator hypothesis” covid-19 pandemic-related in new onset pediatric type 1 diabetes: a retrospective analysis 2010-2022

      hrp0098p2-89
    • Type 1 diabetes incidence in children aged under 15 years living in Ireland during 2022

      hrp0098p2-90
    • Prevalence, clinical, immunological and biochemical characteristics of children with Familial T1D in Kuwait

      hrp0098p2-91
  • Fat, Metabolism and Obesity
  • • Can asprosin be used as a diagnostic biomarker for non-alcoholic fatty liver disease in obese children?

      hrp0098p2-92
    • Prevalence of metabolic syndrome components and atherogenic index in obese nondiabeticchildren: anthropometric comparison with parents

      hrp0098p2-93
    • Phenotype, Genotype and Follow-up of Pediatric Hypertriglyceridemia: An Indian Perspective

      hrp0098p2-94
    • The Effect of Vitamin D Supplementation on Fatty Liver Disease and Insulin Resistance

      hrp0098p2-95
    • Correlation between glucose metabolism disorder and bone turnover markers in obese adolescents

      hrp0098p2-96
    • Improvement of Cardiometabolic Risk Factors and Psychosocial Health in Children and Adolescents with Excess Adiposity following Implementation of a Comprehensive, Multidisciplinary, Personalized, Lifestyle Intervention Program

      hrp0098p2-97
    • The role of Glucagon-Like Peptide 1 Receptor Agonists for Weight Control in Individuals with Acquired Hypothalamic Obesity- A Systematic Review

      hrp0098p2-98
    • Body Composition in Pediatric Patients with Craniopharyngioma following Surgical Treatment

      hrp0098p2-99
    • Dysregulated adipose tissue expansion and impaired adipogenesis in Prader-Willi syndrome children before obesity-onset

      hrp0098p2-100
    • Weight development and neuroendocrine deficits following proton beam therapy in children with craniopharyngioma

      hrp0098p2-101
    • Diagnosis of monogenic obesity: the uncertainty due to the occurrence of VUS has decreased over time. A single center experience of variant follow-up

      hrp0098p2-102
    • Different impact of BMI on bones mineralisation between obese and lean boys: Cross-Sectional Study

      hrp0098p2-103
    • Silent Dangers: How Insulin Resistance and Trimethylamine N-Oxide Fuel Early Atherosclerosis in Obese Children. A preliminary study

      hrp0098p2-104
    • Successful Semaglutide Treatment in Two Sisters with Congenital Leptin Deficiency and Hyperphagia

      hrp0098p2-105
    • Comparative Analysis of the Discriminative Ability of BMI, TMI, and BMI zscore in Establishing Metabolic Syndrome Risk

      hrp0098p2-106
    • Xq27.3-q28 Duplication Containing FMR1 Gene: Case Presentation and Literature Review of Familial X-linked Hypogonadism, Gynecomastia, Short Stature, Intellectual Disability and Obesity Syndrome

      hrp0098p2-107
    • Prevalence and risk factors of Metabolic Associated Fatty Liver Disease (MAFLD) in polish children and adolescents with severe obesity

      hrp0098p2-108
    • Single-center experience in using a once weekly Semaglutide injection in adolescents with obesity +/- Type 2 diabetes

      hrp0098p2-109
    • Identification of menstrual disorders in Polish adolescent girls with severe obesity. Preliminary results of the Polish-German research project on early-onset severe obesity

      hrp0098p2-110
    • The level of vascular endothelial adhesion factor (VEGF) correlate with hyperlipidemia in obese children and type 1 diabetes in important as the marker of cardiovascular disease

      hrp0098p2-111
    • Risk Factors for Obesity in Children with Hypothalamic Masses

      hrp0098p2-112
    • Impact of Semaglutide on body composition, cardiometabolic variables, glycaemic status, and quality of life in adolescents with severe obesity

      hrp0098p2-113
    • The Association between Metabolic markers, Liver function enzymes, Vitamin D level, and Lung Function Tests in Overweight/obese Children with and without Asthma

      hrp0098p2-114
    • Changes in Weight Distribution & Trends in Obesity Prevalence among Children and Adolescents in East Asia: Insights from NCD-RisC Data

      hrp0098p2-115
    • Prevalence of Central Obesity Among Adolescent School Children in Rural Kerala, South India

      hrp0098p2-116
    • A paediatric case of Progeroid Lipodystrophy: diagnosis, follow-up and new insights from a de novo mutation in the POLD1 gene

      hrp0098p2-117
    • Semaglutide treatment for severe obesity after craniopharyngioma surgery with or without radiotherapy

      hrp0098p2-118
    • Use of medical technology and daily weight measurements in the management of severe childhood obesity

      hrp0098p2-119
    • Whole Genome Sequencing reveals a novel leptin splice region variant in two siblings with morbid childhood obesity

      hrp0098p2-120
    • Anthropometric, Laboratory and Clinical Evaluation of Patients with Syndromic Obesity Regarding to Their Genetic Diagnoses

      hrp0098p2-121
    • The role of obesity on lung function in children and adolescents with asthma

      hrp0098p2-122
    • Evaluation of metabolic syndrome risk using metabolic syndrome z-score in Bardet-Biedl Syndrome patients with various genotypes

      hrp0098p2-123
    • Genetic Causes of Obesity in children from a tertiary hospital in UAE

      hrp0098p2-124
    • The Metabolic Effect of Liraglutide as Add on Treatment to Lifestyle Modification on Obese Adolescents in a Tertiary Centre, Riyadh

      hrp0098p2-125
    • First year outcomes in a Paediatric Complications of Excess Weight (CEW) Service

      hrp0098p2-126
    • MC4R variant in a four-generation family with early-onset severe obesity

      hrp0098p2-127
    • Identification and Functional Validation of Rare Missense Variants in PLXNA1 as a Candidate Gene for Severe Early-onset Obesity

      hrp0098p2-128
    • Evaluation of genetic etiology and genotype-phenotype association in endogenous obesity

      hrp0098p2-129
    • Genetic etiology and clinical phenotype of childhood obesity based on whole exon sequencing technology

      hrp0098p2-130
  • Fetal, Neonatal Endocrinology and Metabolism
  • • The Impact of Congenital Hyperinsulinism on Family Finances and Time: A Report from the HI Global Registry

      hrp0098p2-131
    • A rare metabolic disease mimicking starvation hypoglycemia: fructose 1-6 bisphosphatase deficiency

      hrp0098p2-132
    • Experiences of infant feeding in congenital hyperinsulinism: a thematic analysis

      hrp0098p2-133
    • Long-term follow-up of children and adolescents with congenital hyperinsulinism: a 16 years’ single center experience

      hrp0098p2-134
    • Octreotide efficacy and Safety in Children withhyperinsulinism: evidence from two Chinesecenters

      hrp0098p2-135
    • Hypoglycemia workup in pediatric emergency room before and after an implementation of an improved management protocol

      hrp0098p2-136
  • GH and IGFs
  • • Isolated Speech and Mild Global Developmental Delay with Abnormal Genetic Microarray and IGF1 Resistance in a 6-Year-Old Female

      hrp0098p2-137
    • Comparative Growth Trajectories of SGA and AGA Preterm Infants Over the First Five Years

      hrp0098p2-138
    • Postnatal Growth Patterns of Small for Gestational Age Infants Under 1.5 kg Over a Five-Year Period

      hrp0098p2-139
    • Postnatal Growth Trajectories for 5 years for AGA Preterm Infants Born <1.5 kg

      hrp0098p2-140
    • Insight into IGF1 Receptor Gene Mutations: Implications for Growth Disorders and Treatment - A Comprehensive Review

      hrp0098p2-141
    • Comparative Study of Glucose Response to Intramuscular Glucagon in Pediatric Growth Hormone Deficiency and Idiopathic Short Stature: What is the risk of hypoglycemia?

      hrp0098p2-142
    • Retrospective Analysis of Early Growth Patterns in Children Diagnosed with Growth Hormone Deficiency

      hrp0098p2-143
    • Growth Aberrations in a Yemeni Girl with Elevated IGF-1 Due to a PAPPA2 Gene Mutation: A Case Report

      hrp0098p2-144
    • Comparison of growth hormone therapy response according to the presence of growth hormone deficiency in short stature children born small for gestational age in Korea

      hrp0098p2-145
    • Clinical characteristics and treatment efficacy evaluation in Lithuanian cohort patients with severe primary IGF-1 deficiency

      hrp0098p2-146
    • Is somatotropin therapy lowering the risk of SARS-CoV-2 infection in children with growth hormone deficiency and idiopathic short stature?

      hrp0098p2-147
    • The Diagnostic Effectiveness of Low IGF-1 Combined with a Single Insulin Tolerance Test for the Diagnosis of Growth Hormone Deficiency

      hrp0098p2-148
    • Real-world experience of using Long-Acting Growth Hormone Somatrogon in children and adolescents with growth hormone deficiency

      hrp0098p2-149
    • Real-world data on growth hormone therapy adherence using a connected injection device and catch-up growth in children with growth disorders in Serbia

      hrp0098p2-150
    • Quality of Life and Treatment Burden of Greek children and adolescents with growth hormone deficiency

      hrp0098p2-151
    • Successful Treatment of increasing chronic Hypoglycaemia by long acting GH a 15y old girl with reduced GH Secretion

      hrp0098p2-152
    • Evaluation of minutes related to the maximum levels and random basal levels of growth hormone during stimulation test with glucagon

      hrp0098p2-153
    • Two Clinical Cases of Growth Hormone Insensitivity Overlapping Disorders: STAT3 Gain-Of-Function Syndrome and Meier-Gorlin Syndrome

      hrp0098p2-154
    • Short and long-term response to rhGH therapy in short children born at very low birth weight

      hrp0098p2-155
    • Dosage of recombinant human growth hormone across geographic regions at enrolment into the Kabi/Pfizer International Growth Study (KIGS)

      hrp0098p2-156
    • Investigation of Short Stature in a 10-Year-Old Girl with STAT3 Gain-of-Function Syndrome

      hrp0098p2-157
    • Healthcare professional (HCP) perceptions towards Mallya® Connectivity Cap & App for long-acting growth hormone: results from a Slovenia Participatory Study

      hrp0098p2-158
  • Growth and Syndromes
  • • Correlation Patterns in Longitudinal Growth of Preterm AGA Infants with Birth Weight < 1.5 kg Over Five Years

      hrp0098p2-159
    • Early Growth Decline in Children with Growth Hormone Deficiency: A Comparative Study with Emphasis on Rapid Catch-Down Growth during early infancy

      hrp0098p2-160
    • Long-Term Effects of Estrogen and Growth Hormone Replacement on Mortality and Comorbidities in Turner Syndrome

      hrp0098p2-161
    • Leptin, ghrelin, and nesfatin-1 in children born small for gestational age with catch up growth

      hrp0098p2-162
    • Noonan Syndrome: About 21 cases

      hrp0098p2-163
    • Clinical and genetic analysis of ulnar-mammary syndrome caused by a novel TBX3 mutation in a Chinese boy and literature review

      hrp0098p2-164
    • Pattern of growth and pubertal development in a patient with MIRAGE syndrome

      hrp0098p2-165
    • Corticotropin-Independent Cushing's Syndrome in a 6-Year-Old Girl Treated with Bilateral Adrenal Radiofrequency Ablation

      hrp0098p2-166
    • Kenny - Caffey syndrome type 2 - uncommon cause of short stature

      hrp0098p2-167
    • Pediatric Floating-Harbor Syndrome: Clinical Features and Treatment Outcomes in a Cohort of Chinese Children

      hrp0098p2-168
    • Students in Turkey show a continuing positive secular change of height but a worrying increase of overweight in males

      hrp0098p2-169
    • Assessment of Growth Hormone and Gonadotropin-releasing hormone analog combined treatment in patients with Silver-Russell syndrome

      hrp0098p2-170
    • Development and validation of a deep learning algorithm for predicting vitamin D deficiency risk in children using routine laboratory tests

      hrp0098p2-171
    • European Achondroplasia Forum: Are Current Outcome Measures for Achondroplasia Still Fit for Purpose in the Era of Medical Management?

      hrp0098p2-172
    • Prevalence and changes in genetic and clinical abnormalities in growth hormone-treated girls with Turner syndrome: a study from the Belgian-Luxembourgish growth hormone registry (BELGROW)

      hrp0098p2-173
    • A Chinese case report of X-linked acrogigantism caused by Xq26.3 microduplication

      hrp0098p2-174
    • Endocrinopathy in patients with Prader-Willi syndrome: A single center cohort study

      hrp0098p2-175
    • What is The Most Effective Method for Predicting Adult Height in Boys with Constitutional Delay of Growth and Puberty?

      hrp0098p2-176
    • Gastrointestinal symptoms in adolescents and adults with Silver-Russell syndrome

      hrp0098p2-177
    • Co-Occurrence of DNET and Lymphoma in a patient with Noonan syndrome and mutation in PTPN11 gene

      hrp0098p2-178
    • An Uncommon Cause of Short Stature: 18q Deletion

      hrp0098p2-179
    • A Rare Case of Short Stature and Hypergonadotropic Hypogonadism: LIG4 Mutation

      hrp0098p2-180
    • Mimicking the diagnosis - new challenge for pediatric endocrinology?

      hrp0098p2-181
    • Assessment of the life quality of children experiencing growth retardation

      hrp0098p2-182
    • Growth disorders and endocrine problems in children with FASD

      hrp0098p2-183
    • Impact of Growth Hormone Therapy in Small for Gestational Age (SGA)

      hrp0098p2-184
    • A clinical follow-up of 46 Algerian patients with Prader Willi-Syndrome and their endocrine profile

      hrp0098p2-185
    • “Aggrecan mutation in amidst of congenital neuropathy: what is the relevance of an early genetic diagnosis?”

      hrp0098p2-186
    • Chronic autoimmune thyroiditis and Say- Barber -Biesecker- Young- Simpson syndrome: description of a case of unusual association

      hrp0098p2-187
    • A patient with Rahman syndrome presenting with a novel pathogenic mutation and diabetes

      hrp0098p2-188
    • A child with cutaneous-skeletal hypophosphatemia syndrome caused by a mosaic HRAS mutation – outcome of treatment with anti-FGF23 antibody

      hrp0098p2-189
    • Rare Cases of Primary Hypoparathyroidism in Childhood in the Covid-19 Era

      hrp0098p2-190
    • Many faces of Noonan Syndrome - four case reports

      hrp0098p2-191
    • Assessment of the rhGH treatment compliance in children based on data from centres in Poland and Italy

      hrp0098p2-192
    • Impact of Growth hormone therapy in a Child with SOX3 mutation: A Case Study

      hrp0098p2-193
    • Effectiveness of therapy with recombinant human growth hormone (rhGH) in patients with HLHS and short stature

      hrp0098p2-194
    • Severe intrauterine growth retardation and diagnosis of growth hormone deficiency as initial presentation of TEMPLE syndrome

      hrp0098p2-195
    • Early life growth patterns in cystic fibrosis in Infants from western Algeria

      hrp0098p2-196
    • Adult height of children born small for gestational age treated with growth hormone in southern Brazil

      hrp0098p2-197
  • Multisystem Endocrine Disorders
  • • A Correlation Study Between Iron Overload, Chelation Therapy (ICT), and Metabolic Outcomes in β-Thalassemia Major (β-TDT) Patients

      hrp0098p2-198
    • Impact of Iron Chelation Therapy Adherence on Prediabetes Development in Young Adult β-Thalassemia Major Patients: A Comparative Analysis

      hrp0098p2-199
    • Pseudoprecocious puberty and gynaecomastia as presenting features of Peutz-Jeghers Syndrome

      hrp0098p2-200
    • Assessment of genotype-phenotype correlation in children with pseudohypoparathyroidism

      hrp0098p2-201
    • Endocrine Abnormalities and Growth Pattern in Single Large-Scale Mitochondrial DNA Deletion Syndromes

      hrp0098p2-202
    • Hyperthyroidism and type 1 diabetes mellitus in a girl with down syndrome

      hrp0098p2-203
    • Prevelance of endocrine disorders in thalasemic children and adolescents receiving regular blood transfusion

      hrp0098p2-204
    • Congenital disorders of glycosylation (CDG): Endocrinological features in a case of twin siblings with a ALG1 gene defect

      hrp0098p2-205
    • A Case of Pediatric PTEN Hamartoma Tumor Syndrome Presenting with a Breast Mass

      hrp0098p2-206
    • Endocrinological disturbances in patients with ROHHAD syndrome- single center data

      hrp0098p2-207
    • A Case of Kearns-Sayer Syndrome Presenting with Hypoglycaemia and Adrenal Insufficiency

      hrp0098p2-208
    • Acute renal failure as first presentation of APECED in infancy

      hrp0098p2-209
    • Endocrine Phenotypic Variability in Schaaf-Yang Syndrome: Insights from a Case Series

      hrp0098p2-210
  • Pituitary, Neuroendocrinology and Puberty
  • • Impact of GNRH analog therapy on early and fast puberty girls: clinical, radiological and hormonal analysis

      hrp0098p2-211
    • Does precocious puberty and its treatment causes the emotional and behavioral problems in children?

      hrp0098p2-212
    • Saliva sex-hormones as an alternative method for assessment of pubertal status

      hrp0098p2-213
    • Hypersensitivity Reactions to Gonadotropin-releasing Hormone Analogue in Children

      hrp0098p2-214
    • Transition-loop, an educational tool that helps to provide a smooth transition to adult care for the youngster with chronic conditions. “Before transition from adolescent care to adult care - necessary considerations”

      hrp0098p2-215
    • The comparison of the timing of menarche in girls with central precocious puberty following the discontinuation of monthly and 3-monthly Leuprolide acetate

      hrp0098p2-216
    • Multihormonal Pituitary Insufficiency as a Late Manifestation of Traumatic Pituitary Stalk Interruption

      hrp0098p2-217
    • Report of a patient with TUBB3 E410K syndrome: when ‘Moebius syndrome’ does not quite fit

      hrp0098p2-218
    • Adult height in girls with idiopathic central precocious puberty with gonadotropin-releasing hormone agonist and recombinant human growth hormone treatment: a retrospective study

      hrp0098p2-219
    • Association between Attention Deficit Hyperactivity Disorder, Precocious Puberty and Obesity in Korean girls

      hrp0098p2-220
    • Central precocious puberty: from etiologies to outcomes in patients at the vietnam national children’s hospital

      hrp0098p2-221
    • Genetic and clinical heterogenicity in Russian adolescents with congenital isolated hypogonadotropic hypogonadism

      hrp0098p2-222
    • Surgical Treatment and Somatostatin Experience in Growth Hormone-Secreting Pituitary Macroadenoma Due to AIP Mutation

      hrp0098p2-223
    • Successful Experience with Tolvaptan in Syndrome of Inappropriate Secretion of Antidiuretic Hormone

      hrp0098p2-224
    • Description of a cohort of paediatric patients with congenital hipopytuitarism

      hrp0098p2-225
    • A High Rate of abnormal Cranial MRI in Saudi Girls with Central Precocious Puberty: Single Center Experience

      hrp0098p2-226
    • Real Life Efficacy and Safety of Monthly (4-week) and 6-Monthly (24-week) Formulations of Gonadotropin-Releasing Hormone Agonist (GnRHa) Among Children with Central Precocious and Early Fast Puberty

      hrp0098p2-227
    • Can Hypophysitis Mask Pituitary Stalk Germinoma? Insights from a Case Series Analysis

      hrp0098p2-228
    • Prevalence of neuropsychiatric symptoms in children with central precocious puberty with or without central nervous system lesions

      hrp0098p2-229
    • Advancing Endocrine Disorder Diagnosis in Cyprus: The Cyprus Institute of Neurology and Genetics as an ENDO-ERN Reference Center

      hrp0098p2-230
    • Pituitary hypoplasia and Growth hormone deficiency in A patient with Baraitser- Winter syndrome

      hrp0098p2-231
    • A Rare Cause of Ovarian Failure: Transaldolase Deficiency

      hrp0098p2-232
    • Novel GLI2 Mutation in a Girl with mild holoprosencephaly presenting with Pituitary Stalk Interruption Syndrome, Central diabetes insipidus and combined pituitary hormone

      hrp0098p2-233
    • Cranberry as a Cause of Premature Menarche

      hrp0098p2-234
    • A rare case of hypogonadotropic hypogonadism associated with skeletal anomalities: ulnar-mammary syndrome

      hrp0098p2-235
    • Achieving normal near final height in girls with idiopathic central precocious puberty and early puberty following gonadotropin-releasing hormone analog treatment: Predictors

      hrp0098p2-236
    • Central Precocious Puberty in Three Sisters with an MKRN3 Gene Variant

      hrp0098p2-237
    • Vaginal Bleeding in a Severely Premature Infant During the Mini-Puberty Period

      hrp0098p2-238
    • Clinical Follow-Up of a Case Diagnosed with POMC Deficiency Presenting with Hypoglycemia and Cholestasis

      hrp0098p2-239
    • Serum MKRN3 levels in girls with central precocious puberty due to MKRN3 loss-of-function mutation

      hrp0098p2-240
    • Sellar Mass Confused with Craniopharyngioma: Mature Cystic Teratoma

      hrp0098p2-241
    • Single Centre Experience in the Management of Childhood Prolactinoma

      hrp0098p2-242
    • Overweight and obesity in children and young people with CNS tumours

      hrp0098p2-243
    • Rapidly progressing peripheral precocious puberty due to pineal germ cell tumor in a preschool age boy

      hrp0098p2-244
    • Effectiveness of the uterine artery pulsatility index as a non-invasive diagnostic method for precocious puberty and its correlation with pelvic and breast ultrasound findings, bone age, and hormonal profile

      hrp0098p2-245
    • The role of insulin-like growth factor-I in predicting growth velocity during GnRH-agonists treatment for central precocious puberty

      hrp0098p2-246
  • Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology
  • • A novel CUL4B gene variant activating Wnt4/β-catenin signal pathway to 46, XY female with disorders of sex development

      hrp0098p2-247
    • Associations of lifestyle factors with sex hormones among 6-19 years old children and adolescents

      hrp0098p2-248
    • Pubertal virilization in individuals with partial gonadal dysgenesis attributable to DHH mutation: a case report

      hrp0098p2-249
    • Ovotesticular DSD at Mother and Child Center in Cameroon: clinical and biomolecular aspects

      hrp0098p2-250
    • Teen pregnancy in a girl with 45,X/47,XXX-Turner syndrome in the virtual absence of serum AMH and no oocytes in ovarian histology

      hrp0098p2-251
    • Challenges in prenatal and postnatal management of 45,X/46,X, idic (Y) mosaicism

      hrp0098p2-252
    • A Rarely Detected Variant in 46,XX Disorders of Sex Development: Recurrent p.Arg92Trp Variant in NR5A1

      hrp0098p2-253
    • Implication for metabolic heath of using of adolescent PCOS criteria

      hrp0098p2-254
    • Exploring the Clinical Implications of a LARS2 Gene Mutation in a Female Adolescent with Perrault Syndrome

      hrp0098p2-255
    • Normosmic Congenital Hypogonadotropic Hypogonadism caused a missense mutation in the GnRHR gene in a Female Adolescent

      hrp0098p2-256
    • Clinical and Laboratory Characteristics of Children with Congenital Adrenal Hyperplasia (CAH): A Comparative Study of Hypertensive and Normotensive Patients

      hrp0098p2-257
    • Impact of Precocious Puberty on Clinical Management in Pediatric Patients with Congenital Adrenal Hyperplasia

      hrp0098p2-258
    • Fostering Resilience: Exploring Family Support Groups for Girls with Turner Syndrome - A Pilot Study

      hrp0098p2-259
    • Care of transgender children and adolescents in our region: nine years of experience of a multidisciplinary working group

      hrp0098p2-260
    • Attitude of the pediatric endocrinologists in the accompaniment of children with gender diversity: results of a survey

      hrp0098p2-261
    • The correlation between quality of life and anthropometric indicators in boys with delayed puberty

      hrp0098p2-262
    • Frasier syndrome with 46,XY gonadal dysgenesis diagnosed during etiological evaluation of nephrotic syndrome: A case report

      hrp0098p2-263
    • Bilateral cryptorchidism: should be systematically explored?

      hrp0098p2-264
    • Gonadal function and outcome in 46, XX testicular/ovotesticular DSD – first round collection data from the I-DSD Registry study

      hrp0098p2-265
    • Outcome of antenatal treatment in congenital adrenal hyperplasia due to 21 hydroxylase-deficiency in Algeria

      hrp0098p2-266
    • Gynecomastia: Could It be The One and Only Symptom of The Androgen Insensitivity Syndrome?

      hrp0098p2-267
    • An Assessment Of The Quality Of Data On The Phenotypic Spectrum of The External Genitalia In Males In The I-DSD Registry

      hrp0098p2-268
    • Exercise and Eating Behaviors in Transgender and Gender Diverse Adolescents

      hrp0098p2-269
    • A Rare Cause of Primary Ovarian Insufficiency: Novel Homozygous c.2120G>C(p.Arg707Pro) Pathogenic Variant in the MCM8 Gene

      hrp0098p2-270
  • Thyroid
  • • Thyroid Function Changes During Growth Hormone Therapy in Pediatric Patients: A Review and Comparison with Recent Data

      hrp0098p2-271
    • Thyroid function during GH therapy in children with GHD versus those with ISS

      hrp0098p2-272
    • Post-HSCT Graves’s Disease & Autoimmune Hypothyroidism in Toddlers with Severe Combined Immunodeficiency due to RAG1/RAG2 gene mutation: Keep an eye on the thyroid function following HSCT

      hrp0098p2-273
    • Three Cases of Thyroid Hormone Resistance Arising in a Single Family

      hrp0098p2-274
    • Persistent tachycardia in a teenager with Graves’ disease on block and replace therapy

      hrp0098p2-275
    • Delusional psychosis in a 14-year old female with Graves’ Disease

      hrp0098p2-276
    • Atypical Presentation of Childhood Primary Hypothyroidism with Reversible Chronic Kidney Disease stage-2

      hrp0098p2-277
    • Predictive factors of transient congenital hypothyroidism: a retrospective study

      hrp0098p2-278
    • Secondary Hypertriglyceridemia Due to Diabetes Mellitus and Hypothyroidism in A Pediatric Patient

      hrp0098p2-279
    • Neurodevelopmental Outcome in Children with Congenital Hypothyroidism Between 6 to 42 Months of Age – A Cross-Sectional Analytical Study

      hrp0098p2-280
    • Autoimmune Thyroid Disease and Microalbuminuria in Adolescents

      hrp0098p2-281
    • Thyroid hormone profile and autoimmunity in down syndrome

      hrp0098p2-282
    • Evaluation of thyroid function in a pediatric cohort with chronic spontaneous urticaria: a retrospective, monocenter, observational study

      hrp0098p2-283
    • Primary congenital hypothyroidism in three sisters: evidence for clinical relevance of two mutations of hitherto unknown significance

      hrp0098p2-284
    • Levothyroxine poisoning in children is usually benign: A multi-center experience from Turkey

      hrp0098p2-285
    • Five-Year Experience of Diagnosing and Managing Congenital Hypothyroidism through Dried Blood Spot Newborn Screening in Pakistan: A Comprehensive Clinical Profile and Outcome Analysis

      hrp0098p2-286
    • Abstract unavailable

      hrp0098p2-287
    • BRAF mutation in a pediatric patient incidentally discovered with papillary thyroid cancer- case report

      hrp0098p2-288
    • What to do for Atypia of Uncertain Significance in Thyroid?

      hrp0098p2-289
    • Graves disease in children and adolescents, results of a multicenter Algerian study

      hrp0098p2-290
    • A case of papillary thyroid cancer in a boy with an aggravated heredity for medullary thyroid cancer

      hrp0098p2-291
    • Normal Thyroid Gland Size in Healthy Turkish Newborns Living in An Iodine-Sufficient Area: Ultrasonographic Measurements and Comparison of Handheld and Standard Devices

      hrp0098p2-292
    • Prevalence and Predictor Factors of Transient Congenital Hypothyroidism in Resource-limited Setting

      hrp0098p2-293
    • A Family With Thyroid Hormone Resistance resulting from a rare mutation of thyroid hormone receptor beta gene(THRβ)

      hrp0098p2-294
    • Graves' Disease in Children and Adolescents: A 10 years’ retrospective analysis of patients followed in a Single Center

      hrp0098p2-295
  • Late Breaking
  • • Treatment with Continuous Subcutaneous Hydrocortisone Infusion (CHSI) in Children with congenital adrenal hyperplasia (CAH) due to 21 hydroxylase deficiency: An Option for Poorly Controlled Patients

      hrp0098p2-296
    • CYP21A2 genotype and phenotypic manifestation in children with congenital adrenal hyperplasia from a tertiary care center in Eastern India

      hrp0098p2-297
    • A real-world data analysis of 37 pediatric patients with pheochromocytoma and paraganglioma: Evaluation of the concordance between current diagnostic and treatment algorithms and clinical management practices in resource-limited settings

      hrp0098p2-298
    • A novel mutation in type 1 familial glucocorticoid deficiency associated with a deletion of chromosome 9

      hrp0098p2-299
    • Comparison of Steroid Hormone Levels Measured by Immunoassay and Liquid Chromatography-Mass Spectrometry (LC-MS) Methods in the Follow-Up of Patients with Congenital Adrenal Hyperplasia

      hrp0098p2-300
    • Use of a F-Dex Binding Assay to Determine Steroid Response in Patients with Congenital Adrenal Hyperplasia

      hrp0098p2-301
    • Clinical and molecular characteristics of 26 patients with P450 oxidoreductase deficiency: A multicenter study

      hrp0098p2-302
    • Copy number variations from whole exome sequencing in children with skeletal dysplasia

      hrp0098p2-303
    • Basal Ganglia Calcification in Children with Hypoparathyroidism and Pseudohypoparathyroidism: Characterization of Relationships and Clinical and Laboratory Findings

      hrp0098p2-304
    • Clinical Evaluation and Molecular Analysis of Genetic and Epigenetic Inactivation Defects in GNAS in children: A multicenter experience in China

      hrp0098p2-305
    • Genotype and clinical characteristics analysis of nineteen chinese short-stature patients with acan gene variants

      hrp0098p2-306
    • An Observational Study to evaluate levels of Alkaline Phosphatase in Boys with Duchenne Muscular Dystrophy in South Wales

      hrp0098p2-307
    • A Novel homozygous founder mutation in UFSP2 is associated with a distinct form of skeletal dysplasia in Emiratis

      hrp0098p2-308
    • Inadequate immune response post- vaccination and recurrent bacterial infections in a patient with X-linked hypophosphatemia, resolved under Burosumab therapy

      hrp0098p2-309
    • Hypervitaminosis D-induced hypercalcemia in infants: just a simple intoxication?

      hrp0098p2-310
    • Genotype and phenotype characteristics and long-term follow-up of patients with Vitamin D Dependent Rickets Type II (VDDRII): A nationwide multicenter retrospective cross-sectional study

      hrp0098p2-311
    • Infantile Hypercalcemia Type 2 due to a novel compound heterozygous association in the SLC34A1 gene in a neonate with hypercalcemia and nephrocalcinosis

      hrp0098p2-312
    • Correlation of Bone Health Index (BHI) and Metacarpal Index (MCI) with calcium metabolism parameters in children and adolescents

      hrp0098p2-313
    • Bone Health Index (BHI) and Metacarpal Index (MCI) in boys and girls on treatment with aromatase inhibitors

      hrp0098p2-314
    • Semaglutide modulated the gut microbiome composition and improved bile acid profiles in a mouse model of diabetic nephropathy

      hrp0098p2-315
    • A critical role for iron import through the transferrin receptor in developing ß-cells

      hrp0098p2-316
    • A case of A20 haploinsufficiency and type 1 diabetes mellitus in an infant

      hrp0098p2-317
    • Levels of NK cells in a cohort of Bulgarian children with type 1 diabetes

      hrp0098p2-318
    • Sex, age and irisin levels in pediatric type 1 diabetes: a pilot study

      hrp0098p2-319
    • Screening for celiac disease in children and adolescents with type 1 diabetes, what to do?

      hrp0098p2-320
    • Lipid lowering therapy, LDL- and non-HDL-cholesterol in children and adolescents with type 1 diabetes: An analysis based on the DPV registry

      hrp0098p2-321
    • Mauriac syndrome: A rare complication of Type 1 Diabetes Mellitus

      hrp0098p2-322
    • Hypoglycemia and type 2 diabetes mellitus in a patient with endogenous high methanol and his follow up

      hrp0098p2-323
    • HOMA and Matsuda Index as Screening Tests for Cystic Fibrosis Associated Diabetes in Children

      hrp0098p2-324
    • A novel mutation of CGK gene in patient with Diazoxide responsive congenital hyperinsulinism

      hrp0098p2-325
    • Abstract unavailable

      hrp0098p2-326
    • A myostatin inhibitory antibody potentiates the positive effects of insulin on the skeletal muscle and bone phenotype of insulin-deficient diabetic female mice

      hrp0098p2-327
    • Clinical study of glucose metabolism after allogeneic hematopoietic stem cell transplantation for children with β-thalassemia major

      hrp0098p2-328
    • Metformin Maybe Sufficient to Control Glycemia and Delay Insulin Dependency in Obese Children Presenting with Type 1 DM: A Report of 2 Cases

      hrp0098p2-329
    • Bone turnover markers in adolescents with type 1 diabetes before and after low carbohydrate diet versus a Mediterranean diet

      hrp0098p2-330
    • Impact of Diabetes Mellitus on Growth of the Affected Children and Young People - Single Centre Experience from Oman

      hrp0098p2-331
    • Familial Hypercholesterolemia in Saudi Arabia: Clinical Characteristics and Mortality Rate

      hrp0098p2-332
    • Accelerated growth of preadipocyte cultures with TSC1 downregulation might be linked to lipoma development and can be reversed by mTOR or PI3K inhibition

      hrp0098p2-333
    • Predicting metabolically unhealthy obesity in children

      hrp0098p2-334
    • Exploring the clinical outcomes and experiences for young people (12-17) taking Liraglutide for weight loss

      hrp0098p2-335
    • The Role of Spexin in Metabolic Syndrome Among Childhood Obesity

      hrp0098p2-336
    • Abetalipoproteinemia: a case report

      hrp0098p2-337
    • Reducing BMI below the obesity threshold in children aged 6 to <12 years treated with once-daily liraglutide 3.0 mg: A secondary analysis of the SCALE Kids study

      hrp0098p2-338
    • Adipose tissue Ago2-deficiency improves obesity-related body fat distribution and metabolic disorders by reducing miRNA production and promoting BCAA catabolism

      hrp0098p2-339
    • Evaluating the efficacy of the Evira treatment for childhood obesity treatment-a 26- week single arm interventional study in Abu Dhabi, United Arab Emirates

      hrp0098p2-340
    • Risk factors for common obesity among primary school pupils in Batna (Algeria)

      hrp0098p2-341
    • 3-Month real-world setmelanotide hunger and weight outcomes in two French paediatric patients with hypothalamic obesity

      hrp0098p2-342
    • Reshaping of the chromatin landscape and angiogenic process in umbilical vein endothelial cells of small for gestational newborns

      hrp0098p2-343
    • Fluorescence-Guided Laparoscopic Near-Total Pancreatectomy: An Innovative Approach for Infants with Diffuse Congenital Hyperinsulinism—A Case Series

      hrp0098p2-344
    • Association between maternal and fetal Small Chain Fatty Acids and offspring anthropometry during the first year of life in pregnancies with GDM: MySweetheart study

      hrp0098p2-345
    • Dynamic changes in exocrine pancreatic function after near total pancreatectomy in CHI Patients with KATP channel genes variants

      hrp0098p2-346
    • Effects of Music at 432 Hz on Biological Stress Responses in Infants born Preterm and at Term

      hrp0098p2-347
    • Do aromatase inhibitors used during adolescence affect male reproductive function in adulthood? An exploratory study

      hrp0098p2-348
    • Correlation of Pituitary Volume/Size/Height with Clinical Factors in Growth Hormone Deficiency Patients: A Comprehensive Review

      hrp0098p2-349
    • The genetic and clinical aspects of 10 patients with GH-IGF-1 axis gene variants

      hrp0098p2-350
    • Up to 5 years of once-weekly somatrogon treatment in pediatric patients with growth hormone deficiency: results from an open-label extension of a global Phase 3 study

      hrp0098p2-351
    • Predictive factors for growth hormone response in the first year of treatment among children with growth hormone deficiency in Algeria

      hrp0098p2-352
    • Association between isolated growth hormone deficiency and Jansen de Vries Syndrome: a case report from a Romanian Paediatric Endocrinology Department

      hrp0098p2-353
    • The IGF1 generation test as a tool to predict growth response to growth hormone treatment in children with growth hormone deficiency

      hrp0098p2-354
    • A new score for the diagnosis of Growth hormone deficiency in prepubertal children

      hrp0098p2-355
    • Severe oedema during treatment with long acting GH

      hrp0098p2-356
    • Real-world IGF-1 Variations & Its Management in Children on Recombinant Human Growth Hormone (rhGH) Therapy (RIGHT Study)

      hrp0098p2-357
    • Cross-sectional Insights into the Effects of Heavy Metal Mixtures on Height among Korean Preschoolers: Findings from the Korean National Environmental Health Survey Cycles 3 and 4

      hrp0098p2-358
    • High Frequency of Copy Number Variations as Genetic Causes of Failure to Achieve Catch-Up Growth in Small for Gestational Age Children: A Multicenter Study in Korea

      hrp0098p2-359
    • Bone Healt in young patients with Turner Syndrome: crossectional and longitudinal retrospective data

      hrp0098p2-360
    • Assessment of Growth Hormone Treatment in Korean Pediatric Growth Disorders: 11-Year Interim Analysis from the LG Growth Study

      hrp0098p2-361
    • Unusual response to estrogen replacement therapy complicated by ovarian cyst in a girl with Turner syndrome

      hrp0098p2-362
    • Clinical and Genetic Features of Chinese Patients with Geleophysic and Acromicric Dysplasias due to FBN1 Mutations: A Case Series

      hrp0098p2-363
    • The Influence of puberty timing on the development of metabolic Syndrome in Turner Syndrome patients

      hrp0098p2-364
    • The Diagnostic Yield of Exome Sequencing in Idiopathic Short Stature

      hrp0098p2-365
    • The genomic landscape of children with short stature presenting to a tertiary hospital in UAE

      hrp0098p2-366
    • A Novel Case of Lipoatrophy Due to a Non-Pegylated Long-Acting Growth Hormone Somatrogon

      hrp0098p2-367
    • Unusual presentation of Wolfram syndrome in children with urinary tract dysfunctions

      hrp0098p2-368
    • Management challenges of an infant with multiple endocrinopathies with McCune Albright Syndrome: A Case Report

      hrp0098p2-369
    • Multiple acyl coa dehydrogenase deficiency complicated with steroidogenic diabetes: A case report

      hrp0098p2-370
    • An exploration of a data visualisation web application for rare disease registries

      hrp0098p2-371
    • Caregiver-reported quality of life of patients with MCT8 deficiency: results from a cross-sectional survey

      hrp0098p2-372
    • Screen time of children under five years old: repercussions on the habits and parents positioning

      hrp0098p2-373
    • Analysis of serum microplastics in girls with precocious puberty and its correlation with steroid hormones

      hrp0098p2-374
    • Characteristics of pubertal development in turner syndrme along a 20 - year follow-up

      hrp0098p2-375
    • Central Precocious Puberty and MKRN3 variants: new insights into the protein RING finger structure, and on protein ubiquitination and localization

      hrp0098p2-376
    • The etiology of Central Precocious Puberty and the Impact of Gonadotropin-Releasing Hormone Agonist Therapy: Albanian experience

      hrp0098p2-377
    • Serum vascular endothelial growth factor-A (VEGF-A) levels regarding pubertal stage and obesity in girls

      hrp0098p2-378
    • Hypothalamic obesity following craniopharyngioma surgery; what is the role of hypothalamic inflammation and gliosis?

      hrp0098p2-379
    • Effect of recombinant human growth hormone therapy on postoperative lipid metabolism in children with craniopharyngioma

      hrp0098p2-380
    • A Novel and Validated Noninvasive Method for Determining the Onset of Biochemical Puberty and Predicting Imminent Clinical Puberty

      hrp0098p2-381
    • Testosterone Replacement Therapy in adolescents and young adults with Prader-Willi Syndrome: Efficacy and effects on behaviour

      hrp0098p2-382
    • Transcriptome Analysis of Adult Females Previously Affected by Central Precocious Puberty due to DLK1 Mutations

      hrp0098p2-383
    • Incidence study of central precocious puberty in the population of goiás-brazil: the covid-19 pandemic has changed epidemiology

      hrp0098p2-384
    • Integrating Genetic Testing in the Evaluation of Boys with Central Precocious Puberty: A Portuguese Nationwide Study

      hrp0098p2-385
    • Insulin resistance is frequent in non-obese adolescent girls with irregular menstruation and/or clinical hyperandrogenism

      hrp0098p2-386
    • Development and validation of central precocious puberty diagnostic prediction models in girls based on machine learning

      hrp0098p2-387
    • IRS-1 as a key point in the regulation of insulin-sensitivity in granulosa cells from PCOS women

      hrp0098p2-388
    • A comprehensive overview of the changes in IGF system peptides in the follicular fluid (FF) of women with Polycystic Ovarian Syndrome (PCOS) and their relationships with BMI and HMGB1

      hrp0098p2-389
    • Histological Progression and Malignancy Risk in 17β-Hydroxysteroid Dehydrogenase Type 3 Deficiency: Insights from Infancy to Adulthood

      hrp0098p2-390
    • QT Interval Dynamics in Transgender/Gender diverse Adolescents on GnRHa and Gender-Affirming Hormonal Therapy: A Comparative Analysis

      hrp0098p2-391
    • Identification of Three Novel PPP1R12A Variants From Whole Genome Sequencing in Individuals with Differences of Sex Development (DSD)

      hrp0098p2-392
    • Transcriptomic analysis of peripheral blood mononuclear cells reveals immune and metabolic pathways associated with both puberty-blockade and gender-affirming sex hormone therapy in young transgender individuals

      hrp0098p2-393
    • Identification of GNAS somatic variants in whole blood dna from patients with ovarian-origin peripheral precocious puberty using droplet digital pcr

      hrp0098p2-394
    • Development of Age-Adapted Modules for Standardized Clinical Data Collection in individuals with Klinefelter Syndrome

      hrp0098p2-395
    • Study of Novel Genetic Etiologies for Ovarian Dysgenesis reveals high prevalence of pathogenic variants in DNA damage response genes

      hrp0098p2-396
    • The molecular genetic etiology of POI in non-Turner syndrome girls diagnosed in childhood or adolescence: A single-center experience

      hrp0098p2-397
    • Orbital myositis revealing TRAb negative Graves’ disease: an exceptional situation

      hrp0098p2-398
    • Mutations in THRB gene are associated with combined congenital hypothyroidism and TSH resistance

      hrp0098p2-399
    • Children's Thyroid Health: Impact and Recovery Patterns

      hrp0098p2-400
    • Euthyroid graves’ ophtalmopathy in an adolescent sero-negative for TSH receptor autoantibody: a case report

      hrp0098p2-401
    • Evaluation of clinical characteristics and genotype-phenotype correlation of resistance to thyroid hormone receptor Beta (RTHβ) due to THRβ gene mutations

      hrp0098p2-402
• Poster Category 3
• • Adrenals and HPA Axis
  • • Growth and Final Adult Height Outcomes in Pediatric Patients with Salt-Wasting Congenital Adrenal Hyperplasia

      hrp0098p3-1
    • A case of suspected Pigmented primary nodular adrenocortical disease with a Tanner stage inconsistent with testosterone levels

      hrp0098p3-2
    • Towards Universal Congenital Adrenal Hyperplasia Newborn Screening in Indonesia: Knowledge, Perspectives and Experience of Pediatric Residents and Pediatricians

      hrp0098p3-3
    • Bridging Gaps in Congenital Adrenal Hyperplasia Care: Insights from General Practitioners' Knowledge, Attitudes, and Experiences in Indonesia

      hrp0098p3-4
    • 46,XX DSD secondary to Maternal Adrenocortical Tumor

      hrp0098p3-5
    • Induced Adrenal Insufficiency: Case series

      hrp0098p3-6
    • Transient Elevation of DHEAS in Cantu Syndrome

      hrp0098p3-7
    • Rare presentation of catecholamine-secreting tumor in an infant: excessive thirst and polydipsia

      hrp0098p3-8
    • Early Diagnosis and Management of Aldosterone Synthase Deficiency in Infancy: A Case Report

      hrp0098p3-9
    • Letrozole as Treatment for Severely Advanced Bone Age in Children with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

      hrp0098p3-10
    • Primary adrenal insufficiency: casuistry of a third level hospital

      hrp0098p3-11
    • An unusual case of remission of clinically overt autoimmune Addison’s disease in a Pakistani girl

      hrp0098p3-12
    • Focus on the project: ITASAG24, observational, multicenter study comparing Italian regions with and without neonatal screening for Congenital Adrenal Hyperplasia

      hrp0098p3-13
    • Combined Therapy with GnRH Analogue, Aromatase Inhibitor, and Growth Hormone on Adult Height in Non-Classical Congenital Adrenal Hyperplasia: A Case Report

      hrp0098p3-14
    • Cushing's disease in pediatrics. Case report

      hrp0098p3-15
    • Adrenal insufficiency due to bilateral adrenal haemorrhage in a newborn after suffering perinatal asphyxia: a case report

      hrp0098p3-16
    • Surgical interventions in girls with congenital adrenal hyperplasia – Experience from a low middle income country – A preliminary report

      hrp0098p3-17
    • Nephrocalcinosis in one pediatric patient with Congenital Adrenal Hyperplasia. Case report

      hrp0098p3-18
    • A case of primary amenorrhea in a 17-year-old patient

      hrp0098p3-19
    • A case of Familial Glucocorticoid Deficiency

      hrp0098p3-20
    • Pitfalls of Diagnosing 11-OHD in Limited Settings

      hrp0098p3-21
    • X-linked adrenoleukodystrophy: a case series

      hrp0098p3-22
  • Bone, Growth Plate and Mineral Metabolism
  • • Case report for a 15-year-old black girl with genu valgus and abnormal gait

      hrp0098p3-23
    • An Update on Biochemical Findings for Stages of Nutritional Rickets

      hrp0098p3-24
    • Clinical Analysis of the Recombinant Human Growth Hormone Combined with Aromatase Inhibitors in the Treatment of Adolescent Boys with Short Stature

      hrp0098p3-25
    • Effects of gonadotropin-releasing hormone analogues treatment for precocious puberty and rapidly progressive puberty on bone metabolism in girls

      hrp0098p3-26
    • Insight Bone Metabolism Disorders in Pediatric Patients: A Tertiary Hospital Study

      hrp0098p3-27
    • Incomplete penetrance and Variable Expressivity in Monogenic Diabetes

      hrp0098p3-28
    • Rare combinations: Loeys-Dietz Syndrome Type 2 with Type 1 Diabetes mellitus and Loeys-Dietz Syndrome Type 4 with congenital hypothyroidism due to thyroid hypoplasia

      hrp0098p3-29
    • Red flag for the diagnosis of non-nutritional rickets: experience of a single centre in Southern Italy

      hrp0098p3-30
    • Burosumab as a treatment for x-hyposphosphametic rickets:report of two cases

      hrp0098p3-31
    • Growth hormone treatment in a case of cleidocranial dysplasia with growth hormone deficiency

      hrp0098p3-32
    • Rare Presentation of Rare Disease: Case report of Prenatal onset Hypophosphatasia

      hrp0098p3-33
    • Evaluation of Bone Health in Children Treated for Acute Lymphoblastic Leukemia

      hrp0098p3-34
    • Micronutrients, especially zinc, are essential for the proper growth and development of children

      hrp0098p3-35
    • A 5-year-old girl with severe nutritional rickets mimicking hypophosphatemic rickets (XLH)

      hrp0098p3-36
    • A Case of Intravenous Pamidronate Treatment for Steroid-Induced Osteoporosis in a Patient with Rhematic Arthritis

      hrp0098p3-37
    • Burosumab Effectiveness on Pediatric Patients with X-Linked Hypophosphatemic Rickets: A Prospective Single-Center Study

      hrp0098p3-38
    • Phenotypic and Genotypic profile of 1 alpha hydroxylase deficiency: An Experience from West Yorkshire

      hrp0098p3-39
    • Genetic Rickets: Can it be that early?

      hrp0098p3-40
    • New treatment perspectives in hypophosphatasia

      hrp0098p3-41
    • Access to physiotherapy for children with Osteogenesis Imperfecta in Austria

      hrp0098p3-42
    • About a case of Trichorhinophalangien Syndrome

      hrp0098p3-43
    • Congenital hypomagnesaemia in four Algerian families – the need for early diagnosis and treatment to avoid neurodevelopmental delay

      hrp0098p3-44
    • A case report of rare McCune-Albright Syndrome

      hrp0098p3-45
    • Parathyroid adenoma in a 12-year-old boy with incidental hypercalcemia

      hrp0098p3-46
  • Diabetes and Insulin
  • • Children with Type 1 Diabetes and their families Satisfaction with Healthcare Services

      hrp0098p3-47
    • Influence of the Bacillus Calmette-Guérin vaccine on the incidence of cases of type 1 diabetes mellitus in children and adolescents in the Basque Country (last CCAA to withdraw vaccination in Spain)

      hrp0098p3-48
    • Study of the electrical stability of the heart muscle in children with type i diabetes mellitus

      hrp0098p3-49
    • The Effect of Continuous Glucose Monitoring Device Assistance on Glycaemic Control in Children and Adolescents with Type 1 Diabetes Following the 2023 Türkiye Earthquake Doublet: A Multicentre Study

      hrp0098p3-50
    • Mauriac Syndrome: A Clinical Case of a Rare Complication in Pediatric Type I Diabetes Mellitus

      hrp0098p3-51
    • Impact of clinical parameters and glycemic control on microalbuminuria levels in children and youth with type 1 diabetes

      hrp0098p3-52
    • Diabetic Neuropathic Cachexia and Mauriac Syndrome: A Rare Complication of Poorly Controlled Diabetes Mellitus

      hrp0098p3-53
    • Transient Neonatal Diabetes Mellitus in 50 day-old infant in Lebanon

      hrp0098p3-54
    • Diabetic Ketoacidosis post Asparaginase treatment for Acute Lymphoblastic Leukemia in 12 year-old female in Lebanon

      hrp0098p3-55
    • Frequency and associated factors of lipohypertrophy in children and adolescent with type 1 diabetes in a tertiary care centre

      hrp0098p3-56
    • Management of a clinical case of type 1 diabetes in the pre-asymptomatic stage

      hrp0098p3-57
    • Relationship between body mass index and metabolic control in patients with type 1 diabetes mellitus

      hrp0098p3-58
    • Comparative characterization of prediabetes and diabetes mellitus type 2 in adolescents with obesity

      hrp0098p3-59
    • Evaluating the diagnostic utility of Autoantibodies in Korean pediatric diabetes patient

      hrp0098p3-60
    • Case report neonatal DM

      hrp0098p3-61
    • Severe hypertriglyceridaemia and lipaemia retinalis in a child presenting with diabetic ketoacidosis

      hrp0098p3-62
    • Diabetes Mellitus in children with pancreatitis. Report of three cases

      hrp0098p3-63
    • A case of insulin autoimmune syndrome onset at the age of 3

      hrp0098p3-64
    • Clinical characteristics and immunologic analysis of children with type 1 diabetes mellitus

      hrp0098p3-65
    • An Audit Evaluating Omnipod® 5 usage in Patients Under the Care of the Paediatric Diabetes Team at Wythenshawe Hospital

      hrp0098p3-66
    • Screening for hypertension on diabetes annual review

      hrp0098p3-67
    • Early onset Thiamine Responsive Megaloblastic Anemia (TRMA), diabetes mellitus and sensorineural hearing loss, in 7 month infant, case report

      hrp0098p3-68
    • Study of relationship between nephropathy and dyslipidemia in Senegalese children and adolescents with type 1 diabetes

      hrp0098p3-69
    • A Rare Case of Neurofibromatosis Type 1 in a Child with Diabetes Mellitus Type 1

      hrp0098p3-70
    • Examination of Factors Influencing the Remission Period in Patients with Type 1 Diabetes Mellitus

      hrp0098p3-71
    • Cystic fibrosis-related diabetes. Report of two cases

      hrp0098p3-72
    • Recommendations for screening and prevention of bone disorders in children and adolescents with diabetes mellitus type 1

      hrp0098p3-73
    • Establishing the Saudi Pediatric & Youth Diabetes Registry (SPYDR): initial data and challenges

      hrp0098p3-74
    • A Double Enigma: Co-existing Congenital Hypothyroidism and Autosomal Recessive Familial Hyperinsulinemic Hypoglycemia in a Neonate

      hrp0098p3-75
    • The awareness of teachers and medical school workers regarding diabetes in children

      hrp0098p3-76
    • Modified Diabetic Ketoacidosis Protocol - 12-Year Treatment Experience

      hrp0098p3-77
    • Severe case of Obesity and Type 2 Diabetes – where to go when nothing seems to help?

      hrp0098p3-78
    • Comparation between 2 sistems of automated insulin delivery

      hrp0098p3-79
    • Case Series of Five Patients with Thiamine-Responsive Megaloblastic Anemia in the Pakistani Population, a rare form of monogenic diabetes mellitus

      hrp0098p3-80
    • A Case of Stress Hyperglycaemia with Ketoacidosis – Diagnostic Dilemma

      hrp0098p3-81
    • Incidence of new onset type 1 diabetes in children during the covid-19 global pandemic

      hrp0098p3-82
  • Fat, Metabolism and Obesity
  • • The Relation between Obesity and Thyroid Function in Children and Adolescents

      hrp0098p3-83
    • Regulated sports activity is a greater protective factor for obesity than lunch at school, even in a pandemic

      hrp0098p3-84
    • A novel GPIHBP1 mutation of chylomicronemia syndrome: A case report:

      hrp0098p3-85
    • Setmelanotide as treatment for obesity due to leptin receptor (LEPR) deficiency in a child under 6 years of age

      hrp0098p3-86
    • Family-Based Intervention for Overweight Children: Links Between Parental Health Attitudes, Behaviors, and Children's Success

      hrp0098p3-87
    • The effect of breastfeeding duration on body mass index in children: what is the situation in azerbaijan children?

      hrp0098p3-88
    • Effects of early recombinant human growth hormone treatment in young Chinese children with Prader-Willi syndrome

      hrp0098p3-89
    • Gene variants and clinical characteristics of children with sitosterolemia

      hrp0098p3-90
    • Orthopedic manifestations in children with Prader-Willi syndrome

      hrp0098p3-91
    • Obesity in children from 5 to 19 years old at the Vietnam Northern referral center

      hrp0098p3-92
    • Exploring leptin dysfunction in severe early-onset obesity: implications for pediatric health – a preliminary report

      hrp0098p3-93
    • Real-life Experience of Liraglutide Treatment and Weight Control in Obese Adolescents: A Preliminary Study Supported by Psychoanalysis

      hrp0098p3-94
    • Fructose intake is associated with masld in pediatric obesity

      hrp0098p3-95
    • Correlation between the onset of hyperlipidemia and increased IGF-1 concentrations in obese children

      hrp0098p3-96
    • Prevalence and hormonal correlates of arterial hypertension in overweight/obese children

      hrp0098p3-97
    • Morbid obesity revealing a rare genetic disease

      hrp0098p3-98
    • An unusual thrombosis revealing a rare metabolic disease

      hrp0098p3-99
    • Gayet-Wernicke encephalopathy: an exceptional pathology in pediatrics

      hrp0098p3-100
    • Correlation of body mass index and insulin resistance in obese and overweight children and adolescents - a single center study

      hrp0098p3-101
    • Early-onset obesity in a child with developmental delay and autism spectrum disorder (ASD) - a result of a new ADNP gene mutation

      hrp0098p3-102
    • Promising Horizons: The Impact of GLP-1 Agonist Therapy on Pediatric Obesity Outcomes

      hrp0098p3-103
    • First report of a case of Wernicke Encephalopathy due to Acute Avoidance and Restrictive Food Intake in an Adolescent with insatiable hunger due to Melanocortin 4 Receptor Deficiency: a seemingly contradictory combination

      hrp0098p3-104
    • A rare case of Sitosterolaemia in a paediatric patient presenting with multiple xanthomas

      hrp0098p3-105
    • Syndromic and monogenic obesity: Is clinical exome sequencing necessary?

      hrp0098p3-106
    • Clinical, Laboratory, and Molecular Characteristics Of Cases With Early-Onset Obesity: a single-center experience in Egypt

      hrp0098p3-107
    • Challenges in the treatment of complex cases of homozygous familial hypercholesterolemia

      hrp0098p3-108
    • Multidisciplinary approach essential for managing pediatric severe obesity in association with systemic sclerosis and autism spectrum disorder – case report

      hrp0098p3-109
    • Correlation between bone remodeling biomarkers and glucose metabolism in pediatric patients with essential obesity

      hrp0098p3-110
    • Monogenic Obesity in a Familial Cluster: Insights into Laurence-Moon-Bardet-Biedl Syndrome (LMBBS) & Lectin Deficiency associated with Genetic Variants in BBS12 and LEPR Genes

      hrp0098p3-111
    • Evaluating the efficacy of liraglutide in the obesity children

      hrp0098p3-112
    • Infantile Blount’s disease: an unusual presentation of severe early-onset obesity due to LEPR mutation

      hrp0098p3-113
    • Vitamin D and Obesity in children

      hrp0098p3-114
    • Bariatric surgery in adolescents - one center experience

      hrp0098p3-115
    • Genetic Determinants of Egyptian children with early obesity

      hrp0098p3-116
    • Correlation analysis between childhood obesity and adolescent development in Jiangxi Province

      hrp0098p3-117
  • Fetal, Neonatal Endocrinology and Metabolism
  • • A retrospectıve evaluatıon of pedıatrıc patıents admıtted wıth hypoglycemıa ın terms of etıology

      hrp0098p3-118
    • Experience with Octreotide-LAR in Hyperinsulinemic Hypoglycemia

      hrp0098p3-119
    • A challenging case of neonatal electrolyte abnormalities

      hrp0098p3-120
    • Treatment of an infant with congenital hyperinsulinism due to kcnj11-mutation with octreotide via continuous subcutaneous infusion: a case report

      hrp0098p3-121
    • Challenging management of an extreme preterm neonate with persistent hypoparathyroidism

      hrp0098p3-122
    • GLI2 variant associated with hypopituitarism and midline defects

      hrp0098p3-123
    • Cause of Hypoglycemia in a Case with Turner Syndrome: Hyperinsulinemic Hypoglycemia

      hrp0098p3-124
  • GH and IGFs
  • • Impact of Sex Steroid Priming on Growth Hormone Stimulation in Children with Short Stature: A Comparative Study"

      hrp0098p3-125
    • Unusual presentation of Growth hormone presentation (GHD

      hrp0098p3-126
    • A challenging case of Growth hormone deficiency (GHD) during the neonatal period

      hrp0098p3-127
    • Enhancing Diagnostic Accuracy in Growth Hormone Deficiency: A Comparative Analysis of Sex Steroid Priming in Pediatric Short Stature

      hrp0098p3-128
    • Exploring the Impact of Growth Hormone Therapy on Glucose and Insulin Metabolism in Children with GH Deficiency: A Review

      hrp0098p3-129
    • Outcomes of hormone replacement therapy in children with isolated idiopathic growth hormone deficiency

      hrp0098p3-130
    • Comparison of Growth Hormone Stimulation Tests in Prepubertal Children with Short Stature According to Response of Growth Hormone Replacement

      hrp0098p3-131
    • Factors influencing adherence and therapy-related stress in children and adolescents on daily rhGH treatment

      hrp0098p3-132
    • The Role of Insulin-Like Growth Factor-1 (IGF-1) in Diagnosis of Growth Hormone Deficiency from Childhood to Young Adulthood

      hrp0098p3-133
    • Beyond the phenotype. Report of 3 patients with non-typical Noonan Syndrome (NS)

      hrp0098p3-134
    • Exploring healthcare professionals’ perception and intent towards utilisation of digital solutions in the management of growth hormone therapies: A Taiwanese participatory study

      hrp0098p3-135
    • Benefits and risks of integrating digital health solutions in patients receiving growth hormone therapy in Hong Kong: Findings from an experts panel

      hrp0098p3-136
    • Atrioventricular Block in a Patient Small for Gestational Age during hGH Treatment

      hrp0098p3-137
    • Growth hormone deficiency in a child with known GM1 gangliosidosis

      hrp0098p3-138
    • Growth Hormone Therapy in Congenital Tufting Enteropathy: A Case Report and Literature Review

      hrp0098p3-139
    • Celiac Disease associated with Growth Hormone Deficiency treated by Growth Hormone therapy in 2 cases in Lebanon

      hrp0098p3-140
    • A rare cause of short stature: ellis-van creveld syndrome

      hrp0098p3-141
    • Growth Hormone and Scoliosis; Cause or Coincidence?

      hrp0098p3-142
    • GH therapy in idiopatic short stature: an apportunity to always take into

      hrp0098p3-143
    • GHD in Eastern Algeria

      hrp0098p3-144
    • Severe growth deficiency in a patient with extreme short bowel syndrome and growth hormone deficiency - is there an effective treatment option ?

      hrp0098p3-145
  • Growth and Syndromes
  • • The Impact of Growth Hormone Therapy on Glucose Metabolism in Individuals with Turner Syndrome: A Comprehensive Review

      hrp0098p3-146
    • Accuracy of the Algerian Growth Chart in diagnosing growth hormone deficiency

      hrp0098p3-147
    • The Significance of Family History in the Diagnosis of Hereditary Rare Diseases: A Case Report of Misdiagnosed 1q21.1 Microdeletion Syndrome and Literature Review

      hrp0098p3-148
    • A Retrospective Evaluation of Endocrinological Problems in Patients with Down Syndrome

      hrp0098p3-149
    • Peer bullying occurs frequently among school-aged children who are short in stature

      hrp0098p3-150
    • Assessment of growth in children with iron deficiency anemia treated with ferrous iron

      hrp0098p3-151
    • Unusual case of Noonan or Turner Syndrome – Why not think about Escobar Syndrome?

      hrp0098p3-152
    • A case of Albright Hereditary Osteodystrophy (AHO)- Journey to diagnosis

      hrp0098p3-153
    • An unusual association of Beckwith-Wiedemann syndrome with congenital hypothyreosis, cutaneous haemangiomas and diaphragmatic eventration

      hrp0098p3-154
    • A Rare Cause of Short Stature in Boys: Lysineuric Protein Intolerance and Growth Hormone Experience

      hrp0098p3-155
    • Growth Hormone Therapy in a Patient with Leri-Weill Dyschondrosteosis Presenting with Madelung Deformity

      hrp0098p3-156
    • Radiographic features and response to growth hormone therapy for SHOX deficiency: A case series

      hrp0098p3-157
    • A patient with of 45,X/47,XXX mosaic Turner syndrome and unusual presentation

      hrp0098p3-158
    • Results from the first stage of the Programme for early detection and follow-up of children born small for their gestational age in Bulgaria

      hrp0098p3-159
    • Belated diagnosis of Silver-Russell Syndrome (SRS): Presentation of three cases

      hrp0098p3-160
    • Wolf-Hirschhorn syndrome: severe short stature and growth hormone deficiency

      hrp0098p3-161
    • Three cases of rare bone dysplasias

      hrp0098p3-162
    • A case of PIK3CA-related overgrowth syndrome with hypertrophy of the right index finger and upper limb

      hrp0098p3-163
    • Design and objectives of Study 111-902: a multicenter, prospective and retrospective observational study of children with hypochondroplasia

      hrp0098p3-164
    • Turner syndrome: Genotype vs Phenotype correlation

      hrp0098p3-165
    • Temple syndrome

      hrp0098p3-166
    • Efficacy of alternative Somatropine-rhGH treatment for the management of SHOX-related short stature

      hrp0098p3-167
    • Clinical case of a family variant of stown stalling caused by a mutation in the NPR2 gene

      hrp0098p3-168
    • Parental decision-making after receiving a prenatal diagnosis of Turner syndrome: A qualitative interview study

      hrp0098p3-169
    • Growth velocity patterns after pubertal blockage in trans adolescents: one center study

      hrp0098p3-170
    • WGS confirms the diagnosis of MEN1 syndrome in a suspected pediatric MEN1 case from Qatar, a case report

      hrp0098p3-171
    • Noonan syndrome: case report of 4 patients

      hrp0098p3-172
    • Adolescents Growth Pattern in Saudi Population- A wide base population study

      hrp0098p3-173
    • Noonan Syndrome: A case of rare short stature syndrome

      hrp0098p3-174
    • A rare case of short stature in a patient with Klinefelter Syndrome from Kazakhstan

      hrp0098p3-175
    • Evaluation of an infant formula with large, milk phospholipid-coated lipid droplets on long-term growth and adiposity: the saturn study design

      hrp0098p3-176
    • Pseudohypoparathyroidism and Turner syndrome: a case report

      hrp0098p3-177
    • Chromosomal abnormalities and phenotypic features in algerian paediatric population with Turner Syndrome

      hrp0098p3-178
    • Brazilian children with severe short stature and Batter syndrome type 3: a case series

      hrp0098p3-179
  • Multisystem Endocrine Disorders
  • • Sleep disturbances among 4 to 12 year-old Filipino children with drug resistant epilepsy in a Pediatric Tertiary Hospital in the Philippines

      hrp0098p3-180
    • Impact of Nutrition and Endocrinal Complications on Growth Pattern of Children with Sickle cell Disease

      hrp0098p3-181
    • The outcome of ongoing adult endocrine engagement following transition from paediatric care

      hrp0098p3-182
    • An unusual presentation of fucosidosis in a Chinese boy: a case report and literature review

      hrp0098p3-183
    • A Case Presenting with Breast Asymmetry: Diagnostic Process with Associated Syndromic Features

      hrp0098p3-184
    • From endocrine phenotype to hematological diagnosis of Fanconi anemia – apropos of 2 cases

      hrp0098p3-185
    • "Early Recognition and Management of Nephrogenic Diabetes Insipidus in preterm newborn: A Vital Case Study"

      hrp0098p3-186
    • Hypophosphaemic rickets, central precocious puberty and epidermic neavus syndrome

      hrp0098p3-187
    • Hypothyroidism with thyroid gland in place as the initial sign of a rare disease with typical phenotypic characteristics

      hrp0098p3-188
    • Endocrinological sequelae of protein-losing enteropathy in an italian child

      hrp0098p3-189
    • Autoimmune diseases in Turner syndrome

      hrp0098p3-190
  • Pituitary, Neuroendocrinology and Puberty
  • • Exaggerated mini puberty vs central precocious puberty in an extreme preterm female, To treat or not to treat?

      hrp0098p3-191
    • Effect of GNRH treatment of girls with early/precocious puberty on menarche, menstrualcycle status, and onset of menopause

      hrp0098p3-192
    • Height Gain after GnRH agonist Treatment for Precocious Puberty or Early Puberty

      hrp0098p3-193
    • Atypical Presentation of Endocrinal Disorder

      hrp0098p3-194
    • Pituitary Hyperplasia Due to Primary Hypothyroidism – Apropos of 2 Cases

      hrp0098p3-195
    • Giant prolactinoma presenting as unilateral “exophthalmia” – a case report

      hrp0098p3-196
    • Isolated Premature Menarche: Management and Outcomes – A case series from a UK University Teaching Hospital

      hrp0098p3-197
    • A baby grown up with central hypothyroidism

      hrp0098p3-198
    • Giant Rathke's Cleft Cyst Causing Panhypopituitarism

      hrp0098p3-199
    • Gynecomastia in a Patient with Neurofibromatosis Type 1

      hrp0098p3-200
    • A case of Precocious Puberty in a girl with Prader-Willi Syndrome

      hrp0098p3-201
    • Pituitary hyperplasia secondary to primary hypothyroidism (PHPH) in a paediatric patient with fetal alcohol syndrome – A case report

      hrp0098p3-202
    • Pituitary hyperplasia secondary to primary hypothyroidism

      hrp0098p3-203
    • Severe hypoglycemia in a 5-year-old boy with hyperprolinemia and growth hormone deficiency

      hrp0098p3-204
    • Pituitary stalk interruption syndrome: a pathology not to be ignored

      hrp0098p3-205
    • McCune-Albright Syndrome: knowing how to think about it

      hrp0098p3-206
    • Prolactinoma

      hrp0098p3-207
    • Can InhibinB and AMH measurements help in the differential diagnosis of HHI?

      hrp0098p3-208
    • Delayed, disharmonic pubertal development as the leading symptom of IGSF1-deficiency

      hrp0098p3-209
    • Hypergonadotropic hypogonadism in a girl after bone marrow transplantation from a male unrelated donor

      hrp0098p3-210
    • Fahr's syndrome as a manifestation of autoimmune polyendocrinopathy syndrome and its unusual presentation with seizures

      hrp0098p3-211
    • A case of multiple pituitary hormone deficiency with complex brain malformations: anunusual occurence of pituitary stalk interruption syndrome (PSIS)

      hrp0098p3-212
    • Koolen de Vries: a new associated malformation and an additional complex disease?

      hrp0098p3-213
    • Time to Diagnosis and Risk Factors for Central Diabetes Insipidus Complicating Hypoxic-Ischemic Encephalopathy after Return of Spontaneous Circulation

      hrp0098p3-214
    • Empty sella syndrome: a case report

      hrp0098p3-215
    • A Case of Adipsic Diabetes Insipidus with Craniopharyngioma

      hrp0098p3-216
    • Differential Diagnosis of Pituitary Stalk Thickening in Central Diabetes Insipidus

      hrp0098p3-217
    • Hypogonadotropic Hypogonadism due to mutation of KISS1R gene in a 12 years old boy with different approach for treatment

      hrp0098p3-218
    • An unusual cause of precocious puberty in a young boy

      hrp0098p3-219
    • Septo-optic dysplasia and panhypopituitarism: a case report

      hrp0098p3-220
    • Etiology of precocious puberty, 8 years study in a Pediatric endocrine Center in Annaba, Algeria

      hrp0098p3-221
    • Pituitary macroadenoma in a 17-year-old girl - therapeutic difficulties

      hrp0098p3-222
    • Use of Desmopressin Instead of CRH for Inferior Petrosal Sinus Sampling in Children with Clinical Suspicion of Cushing’s Disease

      hrp0098p3-223
    • Delayed diagnosis of congenital hypopituitarism presenting as syndromic obesity

      hrp0098p3-224
    • Management challenges in a pediatric somatotropinoma

      hrp0098p3-225
    • Evaluation of service provision for patients with Precocious Puberty in a District General Hospital

      hrp0098p3-226
  • Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology
  • • A de novo novel heterozygous deletion mutation in steroidogenic factor 1 gene (NR5A1) in a 46,XY female with sex reversal, primary adrenal insufficiency and splenic aplasia: A 13 years follow-up

      hrp0098p3-227
    • The clinical conundrum of mixed gonadal dysgenesis: A case report

      hrp0098p3-228
    • Complete Androgen Insensitivity Syndrome Coexisting with Müllerian Duct Remnants: A Case Report and Literature Review

      hrp0098p3-229
    • Does Primary Ovarian Failure associate with Monogenic Diabetes Mellitus

      hrp0098p3-230
    • A case of isolated transient clitoral hypertrophy in extremely preterm infant with popliteal pterygium

      hrp0098p3-231
    • When phenotype and genotype do not match: Risks to be analyzed

      hrp0098p3-232
    • Spontaneous Puberty in a Boy with Desert Hedgehog (DHH) Mutations with Hypospadia and Cryptorchidism after Stimulation with GNRHa and HCG/FSH during Infancy

      hrp0098p3-233
    • Clinical case of rare association of Treacher Collins syndrome with micropenis and unilateral cryptorchidism in Russian patient

      hrp0098p3-234
    • Comparative Analysis of Clinical Presentation and Hormonal Profiles in Egyptian Pediatric Patients with 11-Beta-Hydroxylase and 21-Hydroxylase Deficient Congenital Adrenal Hyperplasia

      hrp0098p3-235
    • Comparative Analysis of Growth and Hormonal Parameters in Pediatric Patients with 11-Beta-Hydroxylase Deficiency (11OHD) vs. 21-Hydroxylase Deficiency (21OHD)

      hrp0098p3-236
    • Case report: A unusual association: Lipoid CAH and Arnold Chiari I malformation!

      hrp0098p3-237
    • New mutation in the ANOS gene associated with hypogonadotropic hypogonadism, anosmia, synkinesis and renal agenesis

      hrp0098p3-238
    • The influence of the 21-CYP mutation on the development of premature adrenarche in girls of Uzbek nationality

      hrp0098p3-239
    • Delayed puberty: etiological and gender characteristics

      hrp0098p3-240
    • The curious case of a boy with cryptorchidism

      hrp0098p3-241
    • Efficacy of Letrozole in Managing Prepubertal Gynecomastia Associated with Peutz-Jeghers Syndrome: A Case Study

      hrp0098p3-242
    • Aphallia: a case report

      hrp0098p3-243
    • A rare cause of Secondary Amenorrhoea: Sertoli-Leydig cell tumour of ovary associated with DICER-1

      hrp0098p3-244
    • A rare case of Swyer syndrome from Kazakhstan: XY Complete Gonadal Dysgenesis in a young girl with primary amenorrhea

      hrp0098p3-245
    • Central Precocious Puberty in a 4-year-old Male: “A Case Report of Hypothalamic Hamartoma-Induced Early Puberty”

      hrp0098p3-246
  • Thyroid
  • • The Complex Relationship Between Thyroxine Therapy and Growth Outcomes in Pediatric Hypothyroidism

      hrp0098p3-247
    • The Natural Course of Subclinical Hypothyroidism in Children and Adolescents: A Comprehensive Review

      hrp0098p3-248
    • Treating versus Not Treating Subclinical Hypothyroidism (SCH) in Children: A Comprehensive Review

      hrp0098p3-249
    • Thyroxine's Role in Growth and Development: A Review of Clinical Effects

      hrp0098p3-250
    • Comprehensive Review on the Mechanisms of Thyroxine Action on Growth and Brain Development

      hrp0098p3-251
    • Impact of Subclinical Hypothyroidism on Pediatric Health: A Summary of Findings

      hrp0098p3-252
    • Growth hormone deficiency in patients with late detected Hashimoto thyroiditis-how long to wait for treatment

      hrp0098p3-253
    • Chief complaints at initial presentation of children with Graves’ disease

      hrp0098p3-254
    • Encephalopathy in Hashimoto's Thyroiditis: A Case Report

      hrp0098p3-255
    • Van Wyk Grumbach syndrome – an exciting disease with different causes and forms of presentation

      hrp0098p3-256
    • A Case of Amiodarone-Induced Hyperthyroidism

      hrp0098p3-257
    • Challenges in Managing Pediatric Hypothyroidism: A Case of Severe Autoimmune Thyroiditis

      hrp0098p3-258
    • Brain-Lung-Thyroid Syndrome: differences in clinical spectrum in two case reviews

      hrp0098p3-259
    • Evolution of subclinical hypothyroidism in infancy: a single-center longitudinal retrospective cohort study

      hrp0098p3-260
    • Orbital myositis revealing TRAb negative Graves’ disease: an exceptional situation

      hrp0098p3-261
    • ROHHAD

      hrp0098p3-262
    • Urinary iodine concentrations in schoolchildren in Serbia: still too little or too much

      hrp0098p3-263
    • Ophthalmic Involvement in Childhood Graves' Disease: A Report of Two Cases

      hrp0098p3-264
    • Coexistence of autoimmune thyroiditis and juvenile Still disease

      hrp0098p3-265
    • TRAb, a nasty joke: two cases of neonatal hyperthyroidism in newborns of mothers affected by autoimmune hypothyroidism

      hrp0098p3-266
    • Unraveling Refetoff Syndrome: Insights from a Pediatric Endocrinology Case

      hrp0098p3-267
    • An unusual genetic variant in SLC16A2 causing MCT8 deficiency

      hrp0098p3-268
    • The comorbidity of other autoimmune diseases in children with autoimmune thyroid diseases

      hrp0098p3-269
    • Atrophic thyroiditis in a 14-year-old girl who was undiagnosed for 4 years despite growth failure

      hrp0098p3-270
  • Late Breaking
  • • Challenges in Treating Simple Virilizing CAH: A Case of Accelerated Bone Maturation

      hrp0098p3-271
    • Pseudo-hyperkalaemia in Congenital Adrenal Hyperplasia – A Challenge for Clinicians

      hrp0098p3-272
    • A rare cause of acute salt wasting crisis in infancy: Case report of Type 1 aldosterone synthase deficiency with CYP11B2 mutation

      hrp0098p3-273
    • Iatrogenic cushing's syndrome in infants: Clinical and evolutionary aspects

      hrp0098p3-274
    • Effects of gonadotropin-releasing hormone analogue (GnRHa) combined with recombinant growth hormone (rhGH) on growth of girls with central precocious puberty or early and fast puberty

      hrp0098p3-275
    • 11ß -Hydroxylase deficiency presenting with precocious puberty and gigantism: case report

      hrp0098p3-276
    • Study on the mechanism of CWC27 gene variation leading to chondrodysplasia

      hrp0098p3-277
    • Haploinsufficiency of CTCF gene results in chondrodysplasia

      hrp0098p3-278
    • Nutritional rehabilitation in children with idiopathic stunted growth: is it a recovery pattern of growth?

      hrp0098p3-279
    • Skeletal Manifestations in Children with Nephropathic Cystinosis- Single Center Experience

      hrp0098p3-280
    • Cleidocranial dysplasia associated with gh deficiency by auxological criterion: case report

      hrp0098p3-281
    • Fibrous dysplasia of the bone, a disabling complication of McCune Albright syndrome: a case report

      hrp0098p3-282
    • Bone growth deficits correlated with visceral fat mass volume in adolescent girls with severe and extreme obesity

      hrp0098p3-283
    • Dramatic deterioration of subclinical hyperparathyroidism in children and adolescents during the post-COVID-19 period

      hrp0098p3-284
    • To Study The Risk Factors for Type 1 Diabetes Mellitus Among Children and Adolescents in a Tertiary Care Hospital

      hrp0098p3-285
    • Severe hypertriglyceridemia: A rare but serious complication of diabetic ketoacidosis in children

      hrp0098p3-286
    • ABCC8 gene mutations: two mirror reflections

      hrp0098p3-287
    • Improving Diagnosis and Management for Type 1 Diabetes Mellitus (T1DM) among Children and Adolescents, through Introduction of First-ever T1DM Management Guidelines in Kenya

      hrp0098p3-288
    • Three cases of neonatal diabetes mellitus with different clinical courses

      hrp0098p3-289
    • The Impact of Insulin-Induced Lipodystrophy on Glycemic Variability in Pediatric Patients with Type 1 Diabetes

      hrp0098p3-290
    • Safety and Metabolic Outcomes of Medtronic Minimed 780G Initiation at Diagnosis in Children and Adolescents

      hrp0098p3-291
    • Is the diary for self-monitoring of blood glucose levels in children with diabetes reliable?

      hrp0098p3-292
    • Impact of Ramadan fasting on young people with diabetes type 1

      hrp0098p3-293
    • Hepatic glycogenosis in poorly controlled type 1 diabetics: four case reports

      hrp0098p3-294
    • Psychological evaluation in children and adolescents with diabetes mellitus

      hrp0098p3-295
    • Circumstances of diagnosis of type 2 diabetes in children and young adolescents

      hrp0098p3-296
    • Thyroid function and autoimmunity in children type i diabetes

      hrp0098p3-297
    • Nutritional deficiencies and endocrine dysfunction in children with type 1 diabetes and celiac disease

      hrp0098p3-298
    • Coexistence of Autoimmune Disorders in children newly diagnosed with Type 1 Diabetes Mellitus

      hrp0098p3-299
    • Predictive factors of diabetic ketoacidosis in children with newly onset type 1 diabetes: A single center study

      hrp0098p3-300
    • Eosinophilic esophagitis and type 1 diabetes: a case report

      hrp0098p3-301
    • Glycated hemoglobin in diabetes screening: attention to false positives

      hrp0098p3-302
    • Morbid obesity revealing a rare genetic disease

      hrp0098p3-303
    • An unusual thrombosis revealing a rare metabolic disease

      hrp0098p3-304
    • Gayet-Wernicke encephalopathy: an exceptional pathology in pediatrics

      hrp0098p3-305
    • A Rare Cause of Early-Onset Obesity: A Novel Variant in LEPR

      hrp0098p3-306
    • Disorders of the Melanocortin Pathway: From Genetic Inheritance to Clinical Manifestations Based on a Family Case Study

      hrp0098p3-307
    • Studying the correlation between leptin hormone and body mass index in children with alimentary obesity

      hrp0098p3-308
    • Metreleptin dramatically improves the metabolic pattern in a patient with mandibuloacral dysplasia progeroid syndrome (MADaM)

      hrp0098p3-309
    • Efficacy of cinnamon in improving appetite hormones and body fat in adolescents with obesity: A randomized clinical trial

      hrp0098p3-310
    • An Unusual Presentation of Ornithine Transcarbamylase Deficiency Starting from Hyperthyroidism

      hrp0098p3-311
    • Association between Small for Gestational Age and Mental Disorders: A Systematic Review and Meta-Analysis

      hrp0098p3-312
    • Bartter Syndrome Type 2 presenting as transient pseudohypoaldosteronism with hypocalcaemia: a diagnostic dilemma unveiled by genetic testing

      hrp0098p3-313
    • MRI Structural and Functional Changes in Children with Growth Hormone Deficiency: A Chronological Review

      hrp0098p3-314
    • Prevalence and Clinical Associations of Functional Brain Changes in Children with Growth Hormone Deficiency: A Comprehensive Review

      hrp0098p3-315
    • Functional Magnetic Resonance Imaging (fMRI) Findings and Brain Maturity Index in Children with Idiopathic Short Stature and Growth Hormone Deficiency: A Comprehensive Review

      hrp0098p3-316
    • Genetic Findings in Growth Hormone Deficiency and Idiopathic Short Stature: A Comprehensive Review

      hrp0098p3-317
    • Abstract unavailable

      hrp0098p3-318
    • Relevance of the hypoglycemic insulin stimulation test in 486 cases

      hrp0098p3-319
    • Predictive factors of persistent gh deficiency and impact on the final height: a retrospective cohort study

      hrp0098p3-320
    • Etiological aspects of growth failure

      hrp0098p3-321
    • Evaluation of Effects of Using Mobile Treatment Reminder GroConnect on Treatment Compliance and Treatment Response in Patients Receiving Growth Hormone Treatment – Preliminary Results

      hrp0098p3-322
    • Etiology and characteristics of children with short stature in endocrinology department

      hrp0098p3-323
    • Wolf-Hirschhorn syndrome: severe short stature and growth hormone deficiency

      hrp0098p3-324
    • Prevalence and Degree of Structural Changes in Children with Growth Hormone Deficiency: A Comparative Review with Idiopathic Short Stature

      hrp0098p3-325
    • Effect of IM Depot Estradiol on Pubertal Progression and Uterine Development in Turner Girls

      hrp0098p3-326
    • Novel homozygous RTTN variant causing post-natal microcephaly, dwarfism, intellectual delay and micropenis: a case report

      hrp0098p3-327
    • Temple syndrome; genetics and characteristics

      hrp0098p3-328
    • Turner syndrome's malformative and autoimmune profile

      hrp0098p3-329
    • Phosphocalcic profile and orthopedic manifestations in turner syndrome

      hrp0098p3-330
    • Associated clinical abnormalities among patients with Turner syndrome

      hrp0098p3-331
    • Chest Physiotherapy and Growth in preadolescents Algerians Children with Cystic Fibrosis: The Experience of a single center

      hrp0098p3-332
    • Fahr’s Disease presenting with nonfebrile epileptic seizures: Case report and Systematic Literature Review”

      hrp0098p3-333
    • A Case of 21-Hydroxylase Deficiency with Familial Hypercholesterolemia

      hrp0098p3-334
    • Pituitary stalk interruption syndrome: a pathology not to be ignored

      hrp0098p3-335
    • McCune-Albright Syndrome: knowing how to think about it

      hrp0098p3-336
    • CSNK2B mutation: a rare cause of IGHD

      hrp0098p3-337
    • Diagnostic Accuracy of ITT Peak Cortisol Levels for Identifying ACTH Deficiency in Patients with Suspected Hypothalamic-Pituitary-Adrenal (HPA) Axis Dysfunction

      hrp0098p3-338
    • A case of germinoma presented with primary amenorrhae and hypopitutarism

      hrp0098p3-339
    • Pituitary stalk interruption syndrome: Clinical, biological and radiological aspects of 20 cases

      hrp0098p3-340
    • Characteristics and influencing factors of postoperative glucose and lipid metabolism in children with craniopharyngioma

      hrp0098p3-341
    • Growth hormone deficiency and malformative diseases of the pituitary gland: diagnosis and evolutionary particularities in a series of 20 cases

      hrp0098p3-342
    • Primary amenorrhea in a 16-year-old girl

      hrp0098p3-343
    • Effects of probiotic supplementation during childhood on the gut microbiota when puberty onset in lactating female mice

      hrp0098p3-344
    • An extraordinary case, Leydig cell tumor in a 6-year-old girl with significantly elevated 17-OH Progesterone

      hrp0098p3-345
    • Severe Adolescent Androgenization secondary to an Ectopic Hilus Cell Nodule: a Case Report

      hrp0098p3-346
    • A case report of Gonadoblastoma in Turner Syndrome

      hrp0098p3-347
    • A phenotipically female child with Deletion 9p Terminal Syndrome with Sexual Development Disorder - case report

      hrp0098p3-348
    • Clinical characteristics of patients who underwent gonadectomy from a low middle income country

      hrp0098p3-349
    • An unusual presentation of longstanding Hashimoto’s Hypothyroidism with atrophic thyroiditis: Diagnostic challenges and opportunities in a resource poor set up

      hrp0098p3-350
    • Physical and neuropsychiatric development of children with subclinical congenital hypothyroidism does not depend on treatment tactics

      hrp0098p3-351
    • Pediatric hashimoto’s encephalopathy presenting as super refractory status epilepticus

      hrp0098p3-352
    • A rare case of thyroid cancer in an adolescent girl

      hrp0098p3-353